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ABSTRACT 
 
          This study was designed to evaluate the present situation of 
RVF among animal population in different regions of Sudan. The 
study included serosurveillance and diagnosis of suspected RVF 
cases. Two serological tests were used to detect anti-RVFV 
antibodies: Enzyme linked immunosorbent assay (ELISA) and 
Indirect fluorescent antibody test (IFA).   
        Sera were collected and tested in the year 2001 a total of 1351 
(491 bovine, 423 ovine and 437 caprine). Using Sandwich ELISA 
for the detection of anti-RVFV IgG antibody, the overall prevalence 
rate was ranging from 3.4% to 10% in animals from Buram 
(Western Sudan) and Shandi (Northern Sudan) respectively. All 
positive reactions were detected in sheep (15 samples) and goats (1 
sample). 1543 serum samples (612 bovine, 313 caprine and 618 
ovine) were tested by Capture IgM ELISA during 2001. No anti-
RVFV IgM antibody was detected in all these tested sera. 
          In August 2002 a febrile disease spreaded among cattle in 
every locality in Khartoum and River Nile States manifested by high 
abortion rates reaching as high as 70% and deaths of aborted foeti.  
This raised the suspicion of RVF outbreak. Capture IgM ELISA test 
has been developed with an inactivated viral antigen. A total of 107 
bovine serum samples collected from Khartoum and River Nile 
State as follows:  55 samples from East Nile Province, 35 samples 
from Alshajara and 17 samples from the River Nile State, were 
tested for anti-RVF IgM antibodies using Capture IgM ELISA. 
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Thirty one out of these samples were found positive. The percentage 
positivity  was 25.5%, 14.2% 70.5% respectively. 
In the year 2003 no clinical disease was reported. Moreover 
all tested positive in the year 2002 were culled or removed from the 
herds. In the year 2005, about 410 bovine serum samples from El 
damazine (60), Elgadarif (31), Kassala (269) and El showak (50) 
and 257 ovine samples from Kosti and Elshowak were tested for 
anti-RVF IgM antibodies using IgM ELISA. The percentage 
positive was 6.6% and 1.8% in Eldamazine and Kassala 
respectively. No anti-RVFV IgM antibody was detected in the ovine 
sera. 
         In this study Indirect fluorescent antibody test (IFA) was used 
for serological diagnosis of RVF using inactivated antigen, 100 
bovine serum samples were tested for anti-RVF antibodies,23 out of 
these were positive. The degree of agreement between ELISA and 
IFA tests were very high i.e. IFA test can be used in the diagnosis of 
RVF. 
          For early and rapid detection of RVF virus and an efficient 
surveillance system of a single tube reverse transcriptase 
polymerase chain reaction (RT-PCR) method focusing on the NSs 
coding region of the S segment was developed and used RVF virus 
genome, resulting in the synthesis of 363 bp DNA amplifiers were 
detected in RNAs extracted from RVFV vaccine strain (Smithburn) 
and tissues (spleen and liver) from aborted feti. The assay was 
specific for RVFV and did not amplify any other hemorrhagic virus. 
When serial dilutions of RVFV were mixed with DDW, the minimal 
 15
detection limit was 0.5 plaque forming units. The RT-PCR was 
efficient for the detection of RVFV RNA. 
       Entomological surveillance data about mosquitoes in Khartoum 
was recorded during the period of the study.  
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  اﻟﺨﻼﺻــــــﺔ
     
  ﺍﻟﻤﺎﺸﻴﺔ ﺍﻟﺴﻭﺩﺍﻨﻴﺔ ﻓﻲ ﻟﺘﻘﻴﻴﻡ ﻤﺭﺽ ﺤﻤﻰ ﺍﻟﻭﺍﺩﻱ ﺍﻟﻤﺘﺼﺩﻉ ﺩﺭﺍﺴﺔ ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟ  
، ﺍﻟﺸﻭﻙ ، ﻨﻬﺭ ﺍﻟﻨﻴل ، ﺍﻟﺨﺭﻁﻭﻡ  ﺍﻟﻘﻀﺎﺭﻑ  ﻜﺴﻼ ، ﺍﻟﺴﻭﺩﺍﻥ ﻭﻤﺩﻥ ﻋﺩﺩ ﻤﻥ ﻭﻻﻴﺎﺕﻓﻲ 
ﺍﻟﻔﺘﺭﺓ ﻤﻥ  ، ﺍﻟﻨﻴل ﺍﻷﺯﺭﻕ ﺠﺯﺀ ﻤﻥ ﻭﻻﻴﺎﺕ ﻜﺭﺩﻓﺎﻥ ﻭﺩﺍﺭﻓﻭﺭ ﻓﻲ ، ﺍﻟﻨﻴل ﺍﻷﺒﻴﺽ 
  .  ﺸﺘﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻠﻰ ﺍﻟﻤﺴﺢ ﺍﻟﻤﻨﺎﻋﻲ ﻟﻠﻤﺭﺽ ﻭﺘﺸﺨﻴﺼﻪﺇ.  ﻡ5002 ﻭﺤﺘﻰ 1002
ﺴﺘﺨﺩﺍﻡ ﻨﻭﻋﻴﻥ ﻤﻥ ﺍﻻﺨﺘﺒﺎﺭﺍﺕ ﺍﻟﻤﺼﻠﻴﺔ ﻟﻤﻌﺭﻓﺔ ﻨﺴﺒﺔ ﺘﻭﺍﺠﺩ ﺍﻷﺠﺴﺎﻡ ﺇ ﺘﻡ   
ﻹﻨﺯﻴﻤﻲ ﺍﻟﻤﺘﺴﻠﺴل ﺍﻟﻤﻨﺎﻋﻲ ﺍ ﺨﺘﺒﺎﺭ ﺍﻻﺭﺘﺒﺎﻁﺇ  0ﺍﻟﻤﻀﺎﺩﺓ ﻓﻲ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﻓﻲ ﻤﻨﺎﻁﻕ ﺍﻟﻤﺴﺢ
   .( )ASILE
 tnecseroulf tceridnI tset ( tset AFI) ﺭﺍﻟﺘﺄﻟﻕ ﺍﻟﻤﻨﺎﻋﻲ ﻏﻴﺭ ﺍﻟﻤﺒﺎﺸﺨﺘﺒﺎﺭﺇ
  . ydobitna
ﺒﻭﺍﺴﻁﺔ (  ﻤﺎﻋﺯ734 ﻀﺄﻥ ﻭ324  ﺃﺒﻘﺎﺭ ،194) ﻤﺼل  ﻋﻴﻨﺔ1531 ﻡ ﻓﺤﺹــﺤﻴﺙ ﺘ
% 4.3 GgI   ﻤﻌﺩل ﺤﺩﻭﺙ)ASILE(ﺨﺘﺒﺎﺭ ﺍﻻﺭﺘﺒﺎﻁ ﺍﻟﻤﻨﺎﻋﻲ ﺍﻻﻨﺯﻴﻤﻲ ﺍﻟﻤﺘﺴﻠﺴل ﺇ
 ﺒﺭﺍﻡ ﻏﺭﺏ ﺍﻟﺴﻭﺩﺍﻥ ﻭﺸﻨﺩﻯ ﺸﻤﺎل ﺍﻟﺴﻭﺩﺍﻥ ﻜل ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﺔ ﻜﺎﻨﺕ ﻓﻰ ﻓﻰ% 01ﺍﻟﻰ 
  . 1002 ﻓﻰ ﻋﺎﻡMgIﻟﻡ ﻴﺘﻡ ﺭﺼﺩ ﺃﻯ ﻤﻥ  . ﺍﻟﻀﺎﻥ ﻭﻋﻴﻨﺔ ﻭﺍﺤﺩﺓ ﻓﻰ ﺍﻟﻤﺎﻋﺯ
  ﺤﻴﺙ ﻜﺎﻨﺕ ﻫﻨﺎﻟﻙ ﺤﺎﻟﺔ ﺇﺸﺘﺒﺎﻩﻭﺒﺎﺌﻴﺔ ﻨﺘﺸﺭﺕ ﺤﻤﻰﺇ  2002ﻓﻰ ﺃﻏﺴﻁﺱ ﻋﺎﻡ 
 13 )ﺍﻟﻨﻴل ﺒﻴﻥ ﺍﻷﺒﻘﺎﺭ ﻓﻲ ﻜل ﻤﻥ ﻭﻻﻴﺘﻲ ﺍﻟﺨﺭﻁﻭﻡ ﻭﻨﻬﺭ ﻤﺭﺽ ﺤﻤﻰ ﺍﻟﻭﺍﺩﻱ ﺍﻟﻤﺘﺼﺩﻉ
ﺘﻡ . ﻭﻤﻭﺕ ﻓﻰ ﺍﻟﻨﺘﺎﺠﺎﺕ(%07 )ﺠﻬﺎﺽ ﺒﻤﻌﺩل  ﻋﺎﻟﻰﺇﺘﺴﺒﺒﺕ ﻓﻰ ﺤﺎﻻﺕ (    ﺤﺎﻟﺔ
ﻫﺫﻩ ﺍﻟﻌﻴﻨﺎﺕ ,  ﻋﻴﻨﺔ ﻤﺼل ﺒﺎﺨﺘﺒﺎﺭ ﺍﻻﺭﺘﺒﺎﻁ ﺍﻟﻤﻨﺎﻋﻰ  ﺍﻻﻨﺯﻴﻤﻰ ﺍﻟﻤﺘﺴﻠﺴل701ﻓﺤﺹ 
ﺍﻟﺸﺠﺭﺓ ﻭﻋﺩﺩ ﻤﻥ ﺍﻟﻤﻨﺎﻁﻕ ﺒﺸﻨﺩﻯ ﺤﻴﺙ  ﻜﺎﻨﺕ ﻨﺴﺒﺔ ﺍﻻﺼﺎﺒﻪ , ﺠﻤﻌﺕ ﻤﻥ ﺸﺭﻕ ﺍﻟﻨﻴل
  . ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻰ% 07% 2.41, %5.52
ﺼﺎﺒﺔ ﺠﺩﻴﺩﻩ ﻭﺘﻡ ﺍﻟﺘﺨﻠﺹ ﻤﻥ ﻜل ﺍﻟﺤﺎﻻﺕ ﺍﻟﻤﺼﺎﺒﻪ ﺇ ﻡ ﻟﻡ ﺘﻅﻬﺭ 3002ﻋﺎﻡ  ﻓﻰ
  .ﻡ2002 ﻋﺎﻡ ﻓﻰ
ﻋﻴﻨﺔ ﻤﺼل ﻤﻥ ﺍﻻﺒﻘﺎﺭ ﻓﻰ ﻜل ﻤﻥ ﺍﻟﺩﻤﺎﺯﻴﻥ ، 014 ﻡ ﺘﻡ ﻓﺤﺹ 5002ﻓﻰ ﻋﺎﻡ 
% 8.1ﻭ% 6.6ﻜﺴﻼ، ﺍﻟﺸﻭﻙ ﻭﺍﻟﻘﻀﺎﺭﻑ ، ﻨﺴﺒﺔ ﺍﻻﺼﺎﺒﻪ ﻓﻰ ﻜل ﻤﻥ ﺍﻟﺩﻤﺎﺯﻴﻥ ﻭﻜﺴﻼ 
  .ﻥ ﻭﻟﻜﻨﻬﺎ ﻭﺠﺩﺕ ﺴﺎﻟﺒﻪ ﻋﻴﻨﺔ ﻤﺼل ﻤﻥ ﺍﻟﻀﺎ752ﺍﻴﻀﺎ ﻓﺤﺼﺕ .ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻰ
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ﺴﺘﺨﺩﻡ ﺍﺨﺘﺒﺎﺭ ﺍﻟﺘﺄﻟﻕ ﺍﻟﻤﻨﺎﻋﻰ  ﻏﻴﺭ ﺍﻟﻤﺒﺎﺸﺭ ﺤﻴﺙ ﺍﺜﺒﺕ ﻓﻌﺎﻟﻴﺘﻪ ﻭﺴﺭﻋﺘﻪ ﻭﺫﻟﻙ ﺇ
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           .ﺒﺎﻟﺭﻏﻡ ﻤﻥ ﺤﺴﺎﺴﻴﺘﻪ
ﻋﺔ ﻋﺘﺭﻩ ﻓﻲ ﻓﺤﺹ ﺍﻟﻌﻴﻨﺎﺕ ﺤﻴﺙ ﺘﻤﺕ ﺯﺭﺍﺎﻨﺔ ﺍﻷﺤﻴﺎﺀ ﺍﻟﺠﺯﻴﺌﻴﺔ ﺘﻘﺴﺘﺨﺩﺍﻡ ﺇﺘﻡ 
ﻓﻲ  ( nrubhtimS)  ﺇﺴﺘﻴﺭﺍﺩﻫﺎ ﻤﻥ ﺠﻨﻭﺏ ﺃﻓﺭﻴﻘﻴﺎ  ﺘﻡﻟﻘﺎﺡ ﺤﻤﻲ ﺍﻟﻭﺍﺩﻱ ﺍﻟﻤﺘﺼﺩﻉ ﺍﻟﺘﻲ
ﻤﻥ ﺍﻟﻔﻴﺭﻭﺱ ﻭﺘﻡ  ﻤﺽ ﺍﻟﻨﻭﻭﻱﺍﺴﺘﺨﻠﺹ ﺍﻟﺤ,   ( sllec oreV)ﺨﻼﻴﺎ ﺍﻟﺯﺭﻉ ﺍﻟﻨﺴﻴﺠﻲ 
ﺃﻋﻁﻲ  ( RCP-TR) ﻜـﻭﺱ ﻌ ﺍﻟﻴﻭﻟﻴﻤﺭﻴﺯﻱ ﺍﻟﻤﻲﺴﻠﺴﻠﺘ ﺍﻟﺘﻔﺎﻋل ﺍﻟﺨﺘﺒﺎﺭﻩ ﺒﻭﺍﺴﻁﺔ ﺇ
ﻟﺠﻨﻴﻥ   ﻭﻜﺒﺩﺹ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﻤﻥ ﻋﻴﻨﺔ ﻁﺤﺎلﺇﺴﺘﺨﻼ ﺘﻡ  ﺃﻴﻀﺎﹰ ،ﻨﺘﺎﺌﺞ ﺇﻴﺠﺎﺒﻴﺔ
  . ﺍﻟﻤﺼل ﻤﺠﻬﺽ ، ﻟﻡ ﻴﺘﻡ ﺇﺴﺘﺨﻼﺹ ﺍﻟﺤﻤﺽ ﺍﻟﻨﻭﻭﻱ ﻤﻥ
 ﻜـﻭﺱﻌ ﺍﻟﻴﻭﻟﻴﻤﺭﻴﺯﻱ ﺍﻟﻤﻲﺴﻠﺴﻠﺘﺍﻟﺘﻔﺎﻋل ﺍﻟ ﺘﻤﺕ ﺩﺭﺍﺴﺔ ﺤﺴﺎﺴﻴﺔ ﻭﺨﺼﻭﺼﻴﺔ
  .  ﺤﻴﺙ ﺃﻋﻁﻰ ﻨﺘﺎﺌﺞ ﺍﻴﺠﺎﺒﻴﺔﺤﻤﻲ ﺍﻟﻭﺍﺩﻱ ﺍﻟﻤﺘﺼﺩﻉﻟﻤﺭﺽ 
  . ﺃﻴﻀﺎ ﺘﻡ ﺭﺼﺩ ﺩﺭﺍﺴﺎﺕ ﻋﻥ ﺍﻟﺒﺎﻋﻭﺽ ﻓﻲ ﻭﻻﻴﺔ ﺍﻟﺨﺭﻁﻭﻡ
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                            Epidemiology of Rift Valley Fever in the Sudan 
 
INTRODUCTION 
 
          Rift Valley fever (RVF) is a peracute or acute zoonotic 
disease of ruminants in Africa. It is caused by a single serotype of a 
mosquito-borne Bunya virus of the genus Phlebovirus, which 
consists of at least 51 virus serotypes. The disease occurs in climatic 
conditions favoring the breeding of mosquito vectors and is 
characterized by liver damage. The disease is most severe in sheep, 
goats and cattle, in which it produces abortions in pregnant animals 
and a high mortality rate in the newborns. Older non pregnant 
animals, although susceptible to infection, are more resistant to 
clinical disease. There is a considerable variation in the 
susceptibility to RVF in different animal species. Those breeds or 
strains that are exotic to Africa or from areas where RVF is not 
endemic tend to be more susceptible. Camels suffer an inapparent 
infection but abortion rates can be as high as in cattle (OIE, 2004). 
         Humans are susceptible to infection by handling infected 
materials and through transmission by mosquito vectors. Infection 
of  humans by vectors  is  a striking  feature  in  Countries  with 
relatively  small  population  of  animal hosts. In such areas, RVF 
may be recognized first in humans. It has caused a serious  disease 
in laboratory  workers and  must  be  handled  with  high  level   
biosecurity  (OIE,   2004).   
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   The virus caused massive epidemics in animal populations 
across Africa (Eisa et al, 1977). Modifications in the ecology, 
biology of the virus and environmental conditions appeared to be 
responsible for the resurgence and emergence of the virus, (Meegan 
and Bailey. 1989; Peters et al.1994). RVFV has been isolated from 
cattle in Aswan South Egypt in 1977(Abdelwahab et al., 1978) a 
recent epidemic of the disease was once again reported in 1997 the 
virus was recovered from cattle at the University of Assiut, 
(Abdelhakeem et al., 1998). This virus was described for the first 
time in Saudi Arabia in the year 2000 (FA0, 2000).  The virus was 
also recovered from clinically normal, naturally infected horse. Also 
the economic losses attributed to the often-sub clinical disease are 
difficult to estimate, (FAO, 2003).  
This emerging pathogen constitutes a major hazard to many 
African and Asian countries including the Sudan, Egypt, Somalia, 
Mauritania, Saudi Arabia and Yemen, (FAO, 2003).  
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Objectives: - 
1. To conduct cross-sectional serosurveillance of RVF virus 
antibodies in Sudan, 
2. To apply IgM ELISA for diagnosis of RVF.  
3. To conduct serological survey using IgG and IgM ELISA 
detection technique. 
4. Establishment of Reverse Transcriptase Polymerase Chain 
Reaction (RT-PCR) technique for diagnosis of RVF. 
5. Collection of epidemiological data on the disease and its 
vectors.    
      The  information  gained  will   be  used  to  construct  
effective  control  measures that could  be  implemented  in  the  
case  of  outbreaks or  for  animal  trade purposes. 
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                                          CHAPTER 1 
 
1.  LITRATURE REVIEW 
 
1.1. Causative agent:- 
          Rift valley fever virus (RVFV), is a member of the 
phelebovirus genus in the family Bunyaviridae (McIntosh et al., 
1980), mature particles, liberated by the disintegration of Vero cells, 
contained ribosome-like structures within the nucleocapsid, which is 
surrounded by a typical unit membrane through which are inserted 
350-375 surface spikes whose inner ends were incorporated into the 
nucleocapsid structure (Ellis et al., 1988). In the negatively stained 
material, the overall diameter of the virion was 90-110 nm; the 
spikes were 10-18 nm in length and 5 nm in diameter (Ellis et al., 
1988). The viral particles are spherical or pleomorphic, depending 
on the method used for fixation as with all members of the family 
Bunyviridae (Gonzales-Scarano and Nathanson, 1996 ). No 
significant antigenic differences have been detected between RVF 
isolates. 
          The virus is very stable in serum and at temperature lower 
than -60 C0 or after freeze-drying, and in aerosols at 23 C0 and 50-
85% relative humidity.  It is inactivated by lipid solvents ,formalin  
and  pH  below 7, The virus  grows  readily in all continuous cell  
lines  and embryonated chicken eggs as  well  as in  a variety of  
laboratory animals (Seifert, 1996 ).  
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1.1.1. Genome of Rift Valley Fever Virus (RVFV): 
              Like all the phleboviruses, RVF virus possesses a tripartite 
genome consisting of negative sense single-strand RNA segments 
designated L (large), M (medium) and S (small). The L segment 
codes for the L viral polymerase. The M segment codes for the 
precursor to the envelope glycoproteins G1 and G2 and the non 
structural proteins 14 and 78 kDa. The S segment codes for the 
nucleocapsid protein N and the non structural protein sequences 
(NSs) in an ambisense strategy (Vialat et al., 1997) 
1.1.1.1. S segment (Website 1):  
GenBank  Accession Number:  NC-002045. Size: 1690.  
Gene Count: 2 genes. The S segment codes for the nucleocapsid 
protein N and the non structural protein NSs in an ambisense 
strategy (Vialat et al., 1997).  
The gene organization and expression of the S segment are 
the major features that distinguish the Phlebovirus genus from 
Bunya viruses, Hantaviruses, and Nairoviruses, but are similar to 
those Topoviruses (Giorgi, 1996). The sequences and coding 
strategies of the S RNAs of two viruses, Toscana (TOS) and the 
M12 derivative of Rift Valley fever ZH-548 (RVF, Phlebovirus 
genus, Bunyaviridae) have been determined from cDNA clones and 
compared to the previously published sequences of Punta Toro (PT), 
Sand fly fever Sicilian (SFS), and Uukuniemi (UUK) viruses. All 
five viruses exhibit an ambisense coding strategy for their small (S) 
RNA species, i.e., one gene product (the NSs protein) is encoded in 
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the 5' half of the viral RNA, a second (the N protein) is encoded in 
the sequence complementary to the 3' half,(Giorgi et al., 1991). 
1.1.1.2.   M Segment (Website 2):  
Gene Bank Accession Number: NC_002044 M25276 M11157  
Size: 3884 or 3885 bp (Website 2).Gene Count: 2 genes.  
           The M segment codes for the precursor to the envelope 
glycoproteins G1 and G2 and the non structural proteins 14 and 78 
kDa (Vialat et al., 1997). The sequence data show that all viruses 
possess a single large ORF extending the length of the M segment in 
the viral complementary RNA. This ORF codes for a polypeptide 
precursor of the viral glycoproteins G1 and G2 (Giorgi, 1996).  
1.1.1.3. L Segment (Website 3):  
     Gene Bank Accession Number: NC-002043. Size: 6606 
(Website 13) Gene Count: 1 gene.  
The L segment codes for the L viral polymerase (Vialat et al., 
1997).  
1.2. History and World distribution:- 
         RVF virus primarily infects domestic cattle causing massive 
epidemics in human populations across Africa (Eisa et al., 1977).   
           Recently RVF enter Saudi Arabia and Yemen in September 
2000 (Jup.et al., 2002)). Modifications in the ecology, biology of 
the virus and environmental conditions appear to be responsible for 
the emergence of the virus (Meegan and Bailey., 1989; Peters et al., 
1994).Tara (2002) stated that outbreak of RVF is often associated 
with periods of heavy rainfall and construction of dams, after which 
the mosquito population flourishes. 
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          RVF was first identified as an outbreak in exotic wool 
producing  sheep and illness in humans that occurred in the Rift 
Valley of Kenya after heavy rainfall in 1930-31,(FAO,2003). 
Outbreaks have since occurred in the highlands of Kenya at 
irregular intervals of 3-15 years. The most recent epizootic in the 
East African region was in 1997-98 in the drier areas of northeast 
Kenya and southwest Somalia after heavy El Niño-associated rains. 
This caused human deaths and some livestock losses, particularly of 
camels, but more significantly, disruption to livestock exports to the 
Middle East from the Horn of Africa (FAO, 2003). The disease was 
first recorded in the Republic of South Africa in 1950, when a major 
epizootic in South Africa caused an estimated 100 000 deaths and 
500 000 abortions in sheep. A second extensive epizootic occurred 
in Namibia and South Africa in 1974-75. Periodic severe outbreaks 
have also been experienced in Mozambique, Zambia and Zimbabwe 
(FAO, 2003). In 1987 RVF was reported in Mauritania following 
the building of the Diama Dam at the mouth of the Senegal River. 
This is an area where the disease is endemic, but had often existed 
as only an inappernt infection. Never before had RVF been seen 
with such a high morbidity and mortality (Lederberg et al., 1992), a 
further outbreak of the disease occurred there in 1998. 
          In 1973, RVF outbreaks occurred in irrigated areas of the 
Sudan. (FAO, 2003). In 1977, the virus was isolated from infected 
cattle during an epizootic of the disease in Aswan, South Egypt 
(Abdelwahab et al., 1978; Arthur et al., 1993). The disease was 
recognized there and caused an estimated 600 human deaths as well 
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as heavy losses in sheep, goats, cattle, buffaloes and camels along 
the Nile Valley and Delta. RVF outbreaks again occurred in Egypt 
in 1993. (FAO, 2003).  A recent epidemic of the disease was, once 
again, reported in Aswan, Egypt in the summer of 1997, the virus 
was isolated from calves, ((Abdelhakeem et al., 1998).  
           RVF virus is probably present in all countries of sub-Saharan 
Africa. Many of these countries, outside eastern and southern 
Africa, do not have populations of the highly susceptible exotic 
livestock breeds that act as indicators of RVF virus activity. Human 
disease may be the first indication that RVF virus amplification is 
occurring at high levels in these countries, where the indigenous 
ruminants may not show any clinical signs of disease other than 
insignificant low levels of abortion, (FAO. 2003). 
          Until recently RVF was thought to be restricted to Africa. 
However, it was reported in the Tehama area of both Saudi Arabia 
and Yemen in September 2000. The Tehama plain - about 50 km 
wide - is in the west of these countries, between the mountains and 
the Red Sea, on the eastern side of the Great Rift Valley. It is a 
semi-arid zone with alluvial fanning from the mountains that form 
the scarp of the Rift. Its ecological characteristics are similar to 
those in the corresponding western side of the Rift Valley in Africa, 
where RVF occurs. RVF virus activity is highly associated with 
such limited riverine alluvium zones. There were extensive 
abortions in sheep and goats and some 855 severe human cases with 
118 deaths. The virus was similar to that circulating in Kenya and 
Somalia in 1997-98. (FAO, 2003). RVF however, has the potential 
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for further international spread, particularly with the climatic 
changes that might be expected with global warming. High-risk 
receptive areas are, for example, the Tigris/Euphrates Delta zone to 
the northeast in Iraq and the Islamic Republic of Iran, (FAO, 2003) 
It is worth mentioning that, RVFV was thought to be 
diagnosed in 1987 based on clinical signs and histopathological 
findings in the liver of sheep in a farm in the Ankara region and in 
cattle in a farm in southwest Turkey, (Girigin, and Akosoye, 
1988).but was never virologically or serologically confirmed  
In the Sudan, the first survey for antibodies to RVFV in 
human populations was conducted in the Southern region. The 
prevalence of the infection was found to be 6.7% as determined by 
agar gel diffusion test, (Findlay et al., 1936).  
An epizootic of the disease was also reported in Kosti 
District, the White Nile Province of the Sudan in 1973, it covered 
almost every single locality in the District and spread northwards to 
Blue Nile Province and northern part of the White Nile Province. 
Sheep, goats, cattle and humans were involved. (Eisa et al., 
1977).Mortality rates was highest in lambs (96%) followed by goats 
kids and calves (Eisa et al., 1977). Subsequently, the virus was 
isolated and identified as RVFV using serum neutralization test 
(SNT). Hyperimmune rabbit antiserum to the Egyptian strain 
(Zagazig) of RVFV was employed in the SNT (Eisa, and Obeid, 
1977; Eisa et al., 1977). In a later study, Eisa (1984) reported a 
preliminary survey of domestic animals of the Sudan for 
precipitating IgG antibodies to RVFV antigen.  The prevalence of 
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the infection was 34.3% in sheep, 33.2% in cattle, 22% in goats, 
7.9% in camels and 4% in donkeys.  Antibodies to RVFV were not 
detected in sera from horses. Therefore, it was suggested that horses 
are unimportant host in the epidemiology of the disease (Eisa, 
1984).  However, the virus was recovered from, clinically normal, 
naturally infected horse and hence the level of virus infection in this 
animal species has probably not been estimated sufficiently (Eisa, 
1984).  A recent serological survey was conducted in patients 
admitted to Hag Elsafi Hospital, Khartoum North, Sudan, for 
detection of antibodies to RVFV.  Approximately, 3% of the 
patients were recently infected with RVFV, as determined by 
detection of IgM antibodies (Kambal, 1997). 
1.3. Epidemiology:- 
1.3.1. Transmission:- 
                 RVFV is an arthropod-borne virus. The virus is transmitted 
by mosquitoes Aedes or Culex, However, other arthropods, such as 
Culicoides imicola, and ticks may also serve as mechanical vectors for 
RVFV (Eisa et al., 1977). The importance of these vectors and their 
distribution are directly related to the distribution of RVFV strains. In 
Central Sudan, the prevalence of the virus antibodies showed a 
marked seasonal pattern, with the infection level being higher in the 
rainy months which coincided with a high population density of the 
invertebrate vectors (Eisa, et al., 1980). Biological fluids, including 
semen and milk, may serve as a source of infection or play a role in 
the transmission of the disease during viremia (FAO, 2003). However, 
additional research is necessary to confirm this assumption. Based on 
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these surveys, it was concluded that RVFV circulates across the 
Sudan in a south-north range along the River Nile Valley with little or 
no extension to the dry areas on the east and west (Eisa et al., 1980), 
the dissemination out side the African continent to Saudi Arabia. It is 
most probable that the RVFV crossed the Red Sea via the crossing 
winds and thereby reaching the Arabian Peninsula in Asia.  It is 
unlikely also that the virus was introduced in Asia by importation of 
infected animals from the African continent.  If the viral hemorrhagic 
fever reported in Turkey (Girigin and Akosoye, 1988) among sheep 
and cattle were really RVF, the virus would have been carried by 
wind in the same manner. The virus will probably spread to Europe in 
the future.  Bluetongue virus (BTV), an arthropod-borne virus of the 
genus orbivirus in the family Reoviridae (Borden, et al., 1971), might 
have been introduced by wind blown arthropods to Tunisia (Africa) 
and Italy (Europe) simultaneously.  These are different geographical 
locations where BTV has never been reported before (OIE, 2004).  
1.3.2. Non-vector transmission of RVFV:- 
          Unlike, human, non-vector transmission of RVF virus is not 
considered to be important in livestock. The risk of human-to-human 
infection through direct contact appears also to be very low. However, 
in addition to mosquito transmission, humans are easily infected by 
contact with the body fluids of infected animals through contact with 
abraded skin, wounds or mucous membranes or by inhalation of 
aerosols. Thus, the slaughter of infected animals, necropsy procedures 
and laboratory handling of tissues and isolated viruses are activities 
carrying a high risk of disease transmission. (FAO, 2003). 
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           RVF outbreaks have not been seen in urban consumer 
populations suggesting that the fall in pH of meat with maturation 
inactivate the virus. 
          Low concentration of the RVF virus is found in the milk of 
infected animals and the connection has been made between human 
infection and the consumption of raw milk. Clearly this could be a 
significant factor in pastoral communities where raw milk is a major 
component of the diet. (FAO, 2003). 
          It is suspected, and it is highly likely given the high 
concentration of RVF virus in the blood of affected animals, that 
infection can be transferred between animals when they are 
vaccinated or blood sampled in succession with the same needle 
during an epizootic (FAO, 2003). Outbreak of RVF occurs generally 
when particularly heavy, prolong and, often, unseasonal rainfall 
favors the breeding of mosquito vectors. Epidemics in most of 
eastern and southern Africa occur in 5 to 20 year cycles, but, in the 
dry semiarid zones of eastern Africa the periodicity is 15 to 30 year, 
(FAO report, 2003). 
1.3.3. The Environmental Factors:- 
          The environmental conditions appear to play a crucial role in 
the distribution of the arboviruses in any continent, where the activity 
of the vector is likely to be highest during late summer and early fall.  
In contrast, the activity of the vector is usually suppressed during the 
winter season. However, transmission of RVFV during the winter 
season is not uncommon (Peretorius et al., 1997). The overwinternig 
mechanism for viral transmission is yet to be explained. Cyclonic 
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winds and warm temperatures determine how far the infection would 
be transmitted.  The vectors can be carried with the wind for hundreds 
of miles, thus transmitting the infection to different continents, 
(Peretorius et al., 1997).   
1.3.4. Reservoir Hosts:- 
          Since the duration of viremia was not determined in each 
specific ruminant species, it would be extremely difficult to predict 
which animal species is likely to be the reservoir host of the disease.  
Camels may contract the infection during epizootic of RVFV.  
However, the infection is usually subclinical and abortion is the only 
sign of the disease in pregnant she-camel (Eisa et al., 1977). 
Subclinically infected camels and other wild animals could probably 
serve as reservoir hosts for RVFV if viremia persists for a long time in 
these particular animal species. Very little information is available on 
the impact of RVFV in wild animals. In addition, rodents were 
suspected as a potential reservoir of RVFV in South Africa (Peritorius 
et al., 1997). 
          Nothing is known about the susceptibility of avian species to 
RVFV; but this situation may parallel that of Crimean-Congo 
hemorrhagic fever (CCHF). In South Africa, workers in Ostriches 
farm acquired CCHF when handling tick infested slaughtered 
ostriches; the ostriches may serve as amplifying host for the virus 
without showing clinical signs of the disease. Thus providing virus for 
insect transmission to more susceptible animal populations. 
(Swanepool, and Coetzer, 1994). Nevertheless, the exact reservoir 
hosts of RVF virus in different continents are yet to be determined.  
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1.3.5. Populations at Risk:-  
 Studies have shown that sleeping outdoors at night in 
geographical regions where outbreaks occur could be a risk factor 
for exposure to mosquito and other insect vectors. Animal 
herdsmen, abattoir workers, and other individuals who work with 
animals in RVF-endemic areas (areas where the virus is present) 
have an increased risk for infection. International travelers increase 
their chances of getting the disease when they visit RVF-endemic 
locations during periods when sporadic cases or epidemics are 
occurring, (FAO, 2004) 
1.3.6. Inter-epidemic Virus Survival:- 
          During the long interepidemic periods, low levels of virus        
activity may occur in certain foci within the epidemic and enzootic 
areas and these will remain undetected unless intensive surveillance 
activities are carried out. Virus activity may be revealed by random 
isolations from mosquitoes or by occasional human disease. Small 
local RVF outbreaks may occur, when and where the micro-
environmental conditions are favourable and susceptible livestock 
are present. However, the incidence of infection is usually so low to 
be detectable. Clinical disease in humans or animals is generally 
missed in the absence of specific, well-focused active surveillance. 
Transovarian transmission of RVF virus occurs in some species of 
Aedes mosquitoes of the Neomelaniconium group, (Linthicum et al 
1985). The eggs of these mosquitoes, and the virus that they carry, 
may remain viable for very long periods in the mud of dried-up 
surface pools or shallow depressions (locally known as dambos or 
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pans), or in floodplains. Infected mosquitoes hatch from these when 
they are again flooded. This is the reason why the virus persists 
during prolonged interepidemic periods in the grasslands and semi-
arid regions of Eastern, Western and Southern Africa, (FAO, 2003). 
1.3.7. Cryptic or (Sylvatic) RVF:-  
          In Africa, the infection cycle among indigenous, domestic and 
wild vertebrate animals and mosquitoes is subclinical, both in 
livestock and people. In the rain forest and wetter wooded areas of 
the country, the virus circulates silently between wild and domestic 
species and insect vectors. This is referred to as cryptic or sylvatic 
RVF virus activity. Cryptic RVF is extremely difficult to identify 
and occurs in most of the countries of sub-Saharan Africa, (FAO, 
2003). 
1.3.8. The generation of epidemics and inter-epidemic 
persistence of RVF infection:- 
          Recurrent viral activity occurs in localized areas in southern 
and eastern Africa where transmission of RVF virus to ruminants 
occurs during most years. This provides one of the keys to 
understand virus survival during inter-epidemic periods. The other 
key to virus persistence lies in the biology of certain floodwater-
breeding Aedine mosquitoes. These aedine mosquitoes endure dry 
periods as eggs which can survive for long periods, possibly several 
seasons, in dried mud. It is obligatory for these eggs to be subjected 
to periods of drying before they can hatch. RVFV is transmitted 
transovarially in certain Aedes species and infection persists for 
their life. Ideal conditions for the breeding of aedine and other 
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mosquitoes species are found in low-lying shallow depressions, 
termed dambos, which flood when abnormally heavy rainfall raises 
the water table sufficiently. An explosive increase in the aedine 
mosquito vector populations follows with increased transmission of 
RVF virus mainly to cattle, on which they feed selectively. 
Amplification of the virus in cattle provides infection for a range of 
secondary or epidemic mosquito vectors, such as culicine and 
anopheline mosquitoes, which transmit infection to many 
susceptible ruminant species and humans. (FAO, 2003). 
          The generation of epidemics seems generally to be associated 
with the simultaneous intensification of vector and virus activity 
over large areas within which the virus is already present in some 
sites, rather than lateral spreads from cryptic endemic foci. After 
prolonged draughts during which dambos remain dry for many 
years, it is possible that aedine mosquito populations could decline 
to a point where they and RVF virus disappear from large areas. 
Considerable virus amplification would then have to occur before 
the disease again becomes evident or it would need to be 
reintroduced through long range dispersal of viraemic animals or 
infected vectors (FAO, 2003). 
          Flooding and humid weather conditions favour the breeding 
not only of mosquitoes but also of the other biting insects which are 
potential and mechanical transmitters of RVF virus. Eggs of species 
which breed in water, other than those of aedine mosquitoes, cannot 
survive dry conditions and these recolonise flooded dambos from 
nearby rivers or dams. Successions of vector species become 
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available once flooding occurs. Mechanical transmission of 
infection by mosquitoes, midges, phlebotomids, stomoxids, simulids 
and other biting flies appears to play a significant role in epidemics. 
It has been suggested that Hyalomma species ticks on cattle could 
have spread RVF infection to West Africa and Egypt but this is now 
considered unlikely. Ticks appear to play no role in the 
epidemiology of RVF. (FAO, 2003). 
1.3.9. Predictive Epidemiology:- 
          Early work in Kenya showed a close association of epizootic 
RVFV activity with periods of prolonged and heavy rainfall. The 
climate in much of Africa depends upon the characteristics of the 
inter-tropical convergence zone (ITCZ). This is the area of 
convergence of cold air currents from the north of the continent with 
warm air from the south. Its density and magnitude determine the 
levels of cloud cover and precipitation, (FAO, 2003). 
          Initially, prediction of RVF virus activity was made on the 
basis of the occurrence of 2-5 times the mean annual rainfall, which 
caused flooding of grassland water pans or dambo formations. It 
was noticed that such flooded habitat, allowed huge mosquito 
populations to develop at periods when clinical RVF occurred. 
Statistical information was derived from the actual rainfall figures, 
the number of rain days/month and the rolling mean, which 
correlated well with epizootics of RVF over 25 years. (FAO report, 
2003). 
          The advent of Remote Sensing Satellite Imagery (RSSI) 
derived from Landsat, SPOT and later Synthetic Aperture Radar 
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allowed the use of more sophisticated tools to predict RVF epizootic 
activity over much wider areas. Ground truth data was generated to 
correlate with changes in the Cold Cloud Density (CCD) and the 
Normalized Differentiated Vegetation Index (NDVI). This is a 
measure of the intensity of green vegetation. The NDVI index could 
then be correlated with the conditions, which allowed the emergence 
of the Aedes mosquito vectors of RVF. Pilot studies with the NDVI 
values in other parts of Africa have allowed Risk Assessments for 
epizootic RVF to be made, by calculating the difference between the 
normal, expected and the actual rainfall. The initial results appear to 
be promising and may be applicable on a much wider basis to 
similar biotopes in other parts of Africa. Ocean temperature changes 
have now been shown to be correlated with the RSSI data and 
provide a further tool for the prediction of epizootic RVF activity. 
Climatic changes usually occur on a sub-regional basis rather than 
continental (FAO, 2003). 
1.4. Clinical Signs:‐ 
          The most prominent clinical manifestation in all animal 
species involved was severe icterus and abortion according to field 
observations. The duration of the disease is very short extending 
from 2 to 7 days, after which the animals succumbed or recovered 
(Eisa et al., 1980).    
1.4.1. Sheep and goats:- 
          Clinical disease occurs in susceptible sheep (such as imported 
wool sheep) of all ages, but is most severe in young lambs. The 
morbidity rate in infected flocks approaches 100%. The mortality 
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rate may be as high as 95% in lambs less than one week old, about 
40-60% in weaner lambs, and 5-30% in adult sheep. The abortion 
rate may approach 100 %.( OIE, 2004).  
          In peracute cases, sheep are either found dead or suddenly 
weaken and collapse when driven. In acute cases, there is a very 
short incubation period - less than 24 hours - followed by pyrexia, 
rapid pulse, weakness, unsteady gait, vomiting, mucopurulent nasal 
discharge and death in 24-72 hours. Other signs often observed are 
lymphadenitis, colic, hemorrhagic diarrhea and petechial or 
ecchymotic hemorrhages in visible mucous membranes. (OIE, 
2004). 
          Subacute disease is more likely in adult sheep. Diphasic 
pyrexia is accompanied by anorexia and weakness. There may be 
some vomiting and evidence of abdominal pain, with or without 
hemorrhagic gastroenteritis. Hepatitis with jaundice develops in 
most cases. Abortion is an almost inevitable consequence of 
infection of pregnant ewes, and may occur in either the acute or 
convalescent stages of the disease (OIE, 2004). 
          RVF in goats is similar to that in sheep but is usually not quite 
so severe. It is important to remember that the indigenous hair sheep 
and goats in Africa may show none of the above signs and no 
clinical signs other than some abortions. Flocks with or adjacent to 
exotic animals with severe RVF disease may show no signs (FAO, 
2003). 
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1.4.2. Cattle and water buffaloes:- 
          In cattle, as in sheep, the most severe disease is seen in young 
animals. The mortality rate in exotic calves of Bos taurus breeds, 
such as Friesians, may be up to 30 percent, or even higher in 
neonates. Some animals up to 6 and even 12 months may be 
severely ill and debilitated with hepatitis and jaundice for some 
months. The acute disease is similar to that in sheep. In adult cattle 
the mortality rate is less than 2-5% while pregnant cows abort. They 
may show pyrexia, a sharp drop in milk production, lymphadenitis, 
anorexia and malaise. Hemorrhage from the mouth and nares often 
occur, with colic and hemorrhagic diarrhea. In extensively ranched 
cattle, abortions may not be observed and a drop in calving rates 
may be the only sign recognize (OIE, 2004). 
1.4.3. Camels:- 
          Although infection is generally subclinical in mature animals, 
pregnant she-camels may abort at any stage of pregnancy and 
neonatal deaths can occur.  Abortion rates of 70 % of those pregnant 
animals occurred with many deaths in foals 3-4 months of age (Eisa 
et al., 1977). 
1.4.4. Humans:- 
           After an incubation period of two to six days, patients 
experience an influenza-like disease with a sudden onset of fever, 
debility, headache, backache and other muscle pains, and often 
photophobia and vomiting. The fever is diphasic. There is usually a 
degree of liver damage with jaundice. In uncomplicated cases, the 
illness generally resolves itself within a week. Many cases are mild. 
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However, RVF in people who have pre-existing diseases such as 
schistosomiasis or malnutrition may be severe or even fatal.  
Complications of RVF that occur in a small percentage of human 
infections include, (FAO 2003): 
• . Hemorrhagic fever with hepatitis, which is often fatal  
• Meningo-encephalitis.  
• Retinitis, with permanent loss of vision in 1-10% of such 
cases 
1.5.   Pathology:‐ 
          RVFV infected mosquitoes or insect vector transmits the 
infection by biting. The virus invades the subcutis and join the 
lymphatic and eventually reaches the regional lymph nodes where 
initial replication of the virus takes place, the virus joins the blood 
stream causing viremia. Subsequent replication takes place in the 
reticuloendothelial system. The persistence of viremia for along time 
in cattle could probably be explained by the association of the virus 
with blood cells (Aradaib et al, 1997).  In addition, it is probably that 
the virus hides in the liver within the hepatocytes for such a long time. 
The liver is the most seriously affected organ and hence the name 
(enzootic hepatitis), which was, suggested when the virus was 
described for the first time (Daubney, 1931). This is due to destruction 
of the hepatocytes by rapid replication of the virus in this vital organ 
leading to necrotic hepatitis. 
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1.5.1. Gross pathology:- 
          At necropsy the most characteristic lesions in all animal 
species are various degrees of necrosis of the liver and extensive 
jaundice of whole carcasses (Eisa et al., 1980). There are also 
petechial and ecchymotic hemorrhages on all serous surfaces, lymph 
nodes, subcutis and the kidneys and in various tissues. Necropsy 
findings of the peracute cases include necrotic hepatitis particularly in 
young animals, hemorrhagic diarrhea and yellow gelatinous 
subcutaneous and intramuscular edema, pulmonary edema, straw-
colored transudate in the thoracic pericardium and abdominal cavities.  
Hemorrhagic enteritis is associated with bloody diarrhea, 
(Abdelhakeem et al, 1998).When severely affected for example, in 
young lambs the liver is swollen and the capsule becomes tense, 
giving an external impression of firmness. However, on section the 
organ is quite friable, congested and contains many hemorrhages. 
When not masked by blood, the color of the liver ranges from pale 
grey-brown to yellow-brown. Numerous grey-white foci, 1-2 mm in 
diameter, are scattered throughout the parenchyma. The gall bladder 
may be edematous and contain petechial or ecchymotic 
hemorrhages. All lymph nodes are likely to be enlarged, edematous 
and hemorrhagic. (FAO, 2003)  
          The gastrointestinal tract exhibits varying degrees of 
inflammation, from catarrhal to hemorrhagic and necrotic. Petechial 
or ecchymoti hemorrhages are present in most internal organs. 
Ascite, hydropericardium, hydrothorax and pulmonary edema may 
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be present. The fluid in the body cavities is frequently blood stained 
and the carcass is icteric, (FAO, 2003). 
 1.5.2. Histopathology:- 
          In the livers of young animals, there are well-defined primary 
foci of severe coagulative necrosis, which may be centrilobular. 
These are accompanied by diffuse and massive pan-necrosis 
involving most (or all) of the rest of the parenchyma. Some livers 
also show mineralization of scattered necrotic hepatocytes. The 
primary necrotic foci are later infiltrated by histiocytes, 
lymphocytes and neutrophils, many with marked pyknosis and 
karyorrhexis. Intracytoplasmic Councilman-like bodies may be 
present in degenerate hepatocytes or free in sinusoids. Eosinophilic 
inclusion bodies are often found in the nuclei of cells that are still 
recognizable as hepatocytes. In older animals, the hepatic necrosis 
may be less extensive and confined to focal areas of individual 
lobules, (FAO, 2003).  
 1.6. Immunity:‐ 
          IgM antibodies first appear three to five days after the onset 
of RVF clinical signs, at which time viraemia ceases. They persist 
for one to two months, or even three to four months in some 
animals. IgG antibodies appear 10-14 days after the onset of 
infection and persist for at least one to two years or for life. 
Convalescent immunity after natural infection lasts for a long time. 
The offspring of immune mothers may have passively acquired 
maternal immunity for the first three to four months of their lives, 
(FAO, 2003).  
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1.7. Diagnosis of Rift Valley Fever:-  
1.7.1. Field Diagnosis:- 
          RVF epizootics should always be strongly suspected when 
there is a sudden onset of large numbers of abortions in sheep, 
goats, cattle or camels and deaths in lambs, kids or calves. This is 
specially the case if there is surface flooding in savannah or semi-
arid areas following prolonged rains or in irrigated areas, if the 
mosquito populations are high; and if there is concurrent illness in 
human populations, (FAO, 2003).  The disease in domestic animals 
may only be noticed after the illness in people has been identified as 
RVF. There may also be sporadic cases or small outbreaks in non-
epidemic circumstances, which are more difficult to diagnose in the 
field and may therefore be missed. (FAO, 2003)  
1.7.2. Histopathology:- 
     The finding of characteristic histological lesions with pan-
necrosis in the livers of young animals or fetuses is suggestive for 
RVF. 
1.7.3. Laboratory Diagnosis:- 
1.7.3.1. Collection and Transport of Samples:- 
          Whole blood, liver, lymph nodes and spleen are the tissues of 
choice for isolation of the virus. Blood samples should be collected 
from febrile animals into ethylene-diamine-tetra-acetic acid (EDTA) 
or heparin to which antibiotics have been added, (penicillin 200 
units and streptomycin 200 µg/ml, final concentration). Samples of 
liver and spleen should be collected aseptically both from freshly 
dead animals at autopsy and from aborted fetuses, if available, and 
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placed in sterile containers. Duplicate tissue specimens should be 
collected in neutral buffered formalin for histopathology. Blood 
samples, about 20 ml each, should be collected from animals in the 
acute and convalescent phases of the disease, (FAO, 2003). 
       1.7.3.2. Virus Isolation and Identification:- 
              It is recommended that work with this agent should be 
conducted only in Biosafety Level three facilities, which provide for 
High Efficient Particulate Air (HEPA) filtration of all exhaust air 
prior to be discharged from the laboratory, (Sall et al., 1999). 
          Gear (1988) stated that RVF presents a hazard to all laboratory 
workers engaged in its study, and appropriate precautions should be 
taken to prevent infection. These include wearing protective 
clothing including, at the minimum, goggles, mask, waterproof 
apron, and gloves. The handling of the virus should be carried out 
under a hood so designed that the air flows away from the worker to 
the exhaust, and on the way passes through a battery of ultraviolet 
lights and a heated chimney. Laminar-flow hoods which achieve the 
same purpose are standard equipment in most laboratories   
      It is worth mentioning that conventional virus isolation procedures 
 will remain important for recovery of an infectious virus and for 
understanding the biology and ecology of the virus and to study the 
genetic diversity of different strains of RVFV, as re-assortment 
(exchange of genomes between different strains of RVFV) is likely to 
occur in nature (Sall et al., 1999). 
         Various laboratories have different methods for virus isolation 
(VI); RVF virus can be isolated from whole blood or homogenates 
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of fresh tissues by intracerebral inoculation of suckling mice or 
intraperitoneal inoculation of adult mice or hamsters. The identity of 
the isolated virus is confirmed by polymerase chain reaction (PCR), 
enzyme linked immunosorbent assay (ELISA), fluorescent antibody 
staining or virus-serum neutralization tests. 
        African green monkey kidney (Vero) cells or baby hamster 
kidney-21 (BHK-21) cells are used for propagation of RVFV. 
Complete cytopathic effect (CPE) usually occurs in 3-5 days (Eisa 
et al., 1977).But final result requires 2-4 weeks; the serotype-
specific identification of the virus is usually based on serum 
neutralization test using specific hyper immune serum (Eisa et al., 
1977).     
1.7.4. Organism Detection Tests:-  
1.7.4. 1. Electron Microscopy and Fluorescent Test:- 
            RVF virus attained an extracellular titer of at least 3.6 
logs/ml 4 hours post infection in CV-1, Vero and BHK-21 cells. At 
22 hours post infection, a peak titer of 7.7 logs/ ml was reached in 
CV-1 cells, where 50% of the cells showed cytopathic effect. The 
same degree of cytopathic effect was only observed 45 hour post 
infection in the other cell lines tested. At 22 hours post infection, 
RVF viral antigens were detected by indirect fluorescent in the three 
culture systems; however, the degree of fluorescence and the 
number of fluorescent cells were much greater in CV-1 than in 
either Vero or BHK-21 cells. Virus particles were detected by EM, 
22 hours post infection in CV-1 cells, but in Vero and BHK-21 cell, 
the virus could be detected only at 45 hours post infection, (Mekki 
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and Van Der Groen, 1981). Specific identification of RVF antigen 
has been achieved in post-mortem human liver by immunodiffusion 
and in animal tissues by immunofluorescent (Shepherd, 1988). 
1.7.4. 2.Animal Inoculation:- 
            Morrill et al, (1989) stated that   Rhesus monkeys inoculated 
with Rift Valley fever (RVF) virus provide a model in which serial 
observations of serum viral antigen and antibodies can be made. In 9 
non-fatal and 3 fatal infections, either antigen or IgM enzyme-linked 
immunosorbent assay (ELISA) antibodies were detected in every 
serum sample during the acute phase. Furthermore, viral nucleic 
acid could be detected by filter hybridization in most samples taken 
on days 1 to 3. Circulation of significant quantities of viral RNA 
provides an additional approach to the diagnosis and study of RVF.  
1.7.5. Serological Techniques:- 
           Serology may not identify an active infection and cross-
reactions at the serogroup level which are likely to occur with other 
members of the phelebovirus genus. However, it is useful to 
determine past infection in a seroepidemiological survey, (Aradaib 
and Abbas, 1985). Several serodiagnostic techniques have been 
validated for the diagnosis of RVFV. The Agar-gel immunodiffusion 
test (AGID), Complement fixation test (CFT), Enzyme linked    
immunosorbent assay (ELISA), hemagglutination (HA) and 
hemagglut-ination inhibition (HAI) tests are routinely used (Aradaib 
and Abbas, 1985). The use of monoclonal antibodies (Mab) in 
competitive ELISA (cELISA) technique has improved sensitivity and 
specificity at the serogroup level (Aradaib et al., 1994), this technique 
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is applicable only to blood (serum) and requires at least 14 days post 
infection. The ELISA test has now replaced the older 
haemagglutination inhibition (HI), immunofluorescence assay (IFA) 
and serum neutralization tests as the test of choice. ELISA systems 
are available to test for the presence of IgM and IgG, which are 
extremely valuable in epidemiological investigations. The virus 
serum neutralization test in microtitre tissue culture systems is still 
the definitive test system. It is highly specific with little or no cross-
neutralization with other phleboviruses. It can be used to detect 
antibodies in all animal species. However, as it requires the use of 
live virus, it is not recommended for use outside endemic countries 
unless a high level of biocontainment is available in laboratories 
(Sall et al., 1999). 
1.7.5.1.   Sandwich and Capture ELISA:-  
              Paweska et al. (2003) reported the development and validation 
of sandwich and capture ELISAs (both based on inactivated 
antigen) for detection of IgG and IgM antibody to Rift Valley fever 
virus in bovine, caprine and ovine sera. Compared to virus 
neutralisation and haemagglutination-inhibition tests, the IgG 
sandwich ELISA was more sensitive in detection of the earliest 
immunological responses to infection or vaccination with Rift 
Valley fever virus. Its sensitivity and specificity derived from field 
data sets ranged in different ruminant species from 99.05 to 100% 
and from 99.1 to 99.9%, respectively, (Paweska et al., 2003). The 
specificity of IgM-capture ELISA varied between different species 
from 97.4 to 99.4%; its sensitivity was 100% in sheep tested 5-42 
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days post-infection. The results in field-collected, experimental and 
post-vaccination sera demonstrated that these assays might be useful 
for epidemiological surveillance and control programmes, 
import/export veterinary certification, early diagnosis of infection, 
and for monitoring of immune response in vaccinated animals. As 
highly accurate and safe tests, they have the potential to replace 
traditional diagnostic methods, which pose biohazard risks limiting 
their use outside of endemic areas to high containment facilities. 
Serological techniques mentioned previously, despite their advantage 
in detecting infected individuals, are complicated by cross-reactions at 
the level of serogroups and serotypes. To address these problems, 
molecular diagnostic techniques have been developed. 
1.7.5.2. Antigen detection:- 
                   The RVF antigen may be detected by direct or indirect 
immunofluorescence tests on impressions smears or cryostat 
sections of liver, spleen and brain. A rapid diagnosis can sometimes 
be made by agar gel immunodiffusion (AGID) tests on fresh tissues. 
Immunocapture-ELISA and histochemical staining of cryostat 
sections or formalin fixed tissues and PCR are now much more 
widely used for RVF.  
1.7.6. Nucleic Acid Detection Tests:- 
1.7.6. 1. Detection of viral genetic material:- 
          A reverse transcriptase PCR test is now available for 
detection of viral genetic material. Sequencing of the NS (S) 
protein-coding region of the genome may be used for phylogenetic 
analysis (genetic fingerprinting) of virus isolates, (Sall et al., 2001). 
 47
1.7.6.2. Reverse Transcriptase Polymerase chain Reaction (RT-
PCR) 
              RT-PCR is important diagnostic tool for rapid detection and 
differentiation of RVFV infections during endemicity of the disease; it 
has been successfully applied for detection of RNA viruses by 
addition of a complementary DNA (cDNA) synthesis step using 
reverse transcriptase enzyme. (Aradaib et al., 1994). 
1.7.6.3. Real Time RT- PCR:-  
          Viral hemorrhagic fevers (VHFs) are acute infections agents 
with high case fatality rates. Important VHF agents are Ebola and 
Marburg viruses (MBGV/EBOV), Lassa virus (LASV), Crimean-
Congo hemorrhagic fever virus (CCHFV), Rift Valley fever virus 
(RVFV), dengue virus (DENV), and yellow fever virus (YFV). 
VHFs are clinically difficult to diagnose and to distinguish; a rapid 
and reliable laboratory diagnosis is required in suspected cases.  Six 
one-step, real-time reverse transcription-PCR assays for these 
pathogens have been established, (Drosten et al., 2002), based on 
the Superscript reverse transcriptase-Platinum Taq polymerase 
enzyme mixture. Novel primers and/or 5'-nuclease detection probes 
were designed for RVFV, DENV, YFV, and CCHFV using the 
latest DNA database entries. PCR products were detected in real 
time on a Light Cycler instrument by using 5'-nuclease technology 
(RVFV, DENV, and YFV) or SybrGreen dye intercalation 
(MBGV/EBOV, LASV, and CCHFV). (Drosten et al., 2002). The 
inhibitory effect of SybrGreen on reverse transcription was 
overcome by initial immobilization of the dye in the reaction 
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capillaries. Universal cycling conditions for SybrGreen and 5'-
nuclease probe detection were established. Thus, up to three assays 
could be performed in parallel, facilitating rapid testing for several 
pathogens. All assays were thoroughly optimized and validated in 
terms of analytical sensitivity by using in vitro-transcribed RNA. 
The 95% detection limits as determined by probit regression 
analysis ranged from 1,545 to 2,835 viral genome equivalents/ml of 
serum (8.6 to 16 RNA copies per assay). The suitability of the 
assays was exemplified by detection and quantification of viral 
RNA in serum samples of VHF patients (Drosten et al., 2002). 
Primers:  
RVS and RVAs  
Forward: RVS AAAGGAACAATGGACTCTGGTCA [349-371]  
Reverse: RVAs CACTTCT TACTACCATGTCCTCCAAT [443-
417]  
Product:  Size: 94 bp  
1.7.6.4. RT- PCR:- 
              Sall et al., (2001), recorded that single tube or a nested 
reverse transcriptase polymerase chain reaction (RT-PCR) method 
focusing on the NSs coding region of the S segment was developed 
and used to detect the RVF virus (RVFV) genome, resulting 
respectively in the synthesis of 810 and 662 bp DNA amplifiers. 
The assay was specific for RVFV and did not amplify any other 
phleboviruses known to circulate in sub-Saharan Africa. When 
serial dilutions of RVFV were artificially mixed with human normal 
serum, the minimal detection limits were 50 and 0.5 plaque forming 
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units respectively using the simple and the nested RT-PCR. The RT-
PCR method was efficient for the detection of RVFV RNA in the 
blood from experimentally RVFV-infected mice and lamb and the 
nested RT PCR was found more sensitive than the virus isolation 
method. Additionally, this detection method was applied 
successfully for the diagnosis of human cases during the 1998 
Mauritanian outbreak.  
Primers:  
 NSca and NSng  
Forward: NSca primer 5'-CCTTAACCTCTAATCAAC-3'  
Reverse: NSng 5'-TATCATGGATTACTTTCC-3'  
NS3a and NS2g  
Forward: NS3a 5'-ATGCTGGGAAGTGATGAGCG-3'  
Reverse: NS2g 5'-GATTTGCAGAGTGGTCGTC-3'  
Product Size: 810 bp  
1.7.6.5. RT -PCR used in Mosquito:-  
           A reverse transcriptase-polymerase chain reaction (RT-PCR) 
assay to detect Rift Valley fever (RVF) virus RNA in 
experimentally infected mosquitoes was developed. The specificity 
of the assay was evaluated with three other phleboviruses namely; 
sandfly fever Sicilian (Sabin), sandfly fever Naples (Sabin) and 
Punta Toro (MSP 3) viruses. The relative sensitivity of the assay, 
determined by using RVF virus RNA extracted from serial dilutions 
of virus culture, was approximately 50 plaques forming units. This 
sensitivity level was 100-fold higher when a nested PCR procedure 
was used. When the RT-PCR assay was used with coded samples of 
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intrathoracically-infected and uninfected mosquito, the assay 
detected the virus in all infected mosquitoes. With this assay, it was 
possible to detect RVF virus RNA in a single infected mosquito in 
the background of 10, 25 or 50 uninfected mosquitoes (Ibrahim et 
al., 1997).  
Primers:  
RVF1 and RVF2  
Forward: RVF1 777/ 5' GAC TAC CAG TCA GCT CAT TAC C 
3'/798  
Reverse: RVF2 1327/5' TG TGA ACA ATA GGC ATT GG 
3'/1309  
Product Size: 551 bp  
RVF3 and RVF4  
Forward: RVF3 876/5' CAG ATG ACA GGT GCT AGC 3'/893  
Reverse: RVF4 1249/5' CT ACC ATG TCC TCC AAT CTT GG 
3'/1228  
Product Size: 374 bp       
1.7.7. Differential Diagnosis:- 
          Different members of the arthropod-borne viruses may 
produce clinical signs and pathological lesions indistinguishable 
from those induced by RVFV.  These viruses include bluetongue 
virus (BTV) and epizootic hemorrhagic disease Virus (EHDV).  
BTV and EHDV are closely related members of the orbivirus genus 
in the family Reoviridae, (Borden et al., 1971).  BTV is primarily a 
disease of sheep and some breeds of deer. Evaluation of a multiplex 
RT-PCR for simultaneous detection and differentiation of North 
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American serotypes of BTV and EHDV was developed very 
recently (Aradaib et al., 2000).  Bovine ephemeral fever and 
Wesselsborne disease may also be confusing during RVFV 
epizootic (Blood et al, 2000). Malignant ovine theileriosis (Theileria 
lestoqudri) and some bacterial diseases may also confuse diagnosis.   
1.8. Prevention and Control:-  
              The investigation for the focus of the infection is very crucial 
in the control of the disease. Human and veterinary hospitals and 
clinical centers offer an excellent opportunity of establishing 
community relations and furthering social awareness of the impact of 
communicable diseases that occur in the locality. This information is 
cheaper than survey.  Database should be established in these 
hospitals and clinics to assist in tracing the environmental source of 
the emerging viral pathogen or the disease and hence plays an 
important role in understanding their natural history (Aradaib and 
Abbas, 1985).  In Sudan, RVFV epizootic was first described in 1973 
at Kosti, the White Nile Province. Since then, no epizootic has been 
reported in the Sudan until June of 1976. At that particular point in 
time, an epizootic of RVFV was reported in Kuku dairy farm, 
Khartoum North, Sudan. The virus was isolated from a Kenana cow 
in that farm brought from the same locality where the first RVFV 
epizootic was reported (Eisa et al., 1980).  This information will help 
in tracing the source of the disease and hence identifying the critical 
control point. 
          Importation of animals from endemic areas to RVFV-free areas 
should be restricted to vaccinated animals to prevent further 
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dissemination of the virus during RVFV epizootic, especially when it 
is recognized that vaccination during epizootic is not a valid option.  
Moreover, an attenuated strain of RVFV is probably circulating in 
Kuku, Central Sudan.  
 Prevention and control of RVFV infections are dictated by 
climatic conditions. Control of the disease by destruction of vector 
species of the mosquito or the insect is expensive, extremely 
difficult, and is not a valid option in a vast country, like the Sudan, 
specially when it is recognized that reintroduction of the vectors via 
the wind from the surrounding territories is likely to occur. The 
control measures should be aimed at minimizing contact between 
susceptible animals and vectors, particularly during RVFV seasons.  
The use of insect-secured houses and insect repellents for 
susceptible ruminants should be considered during the flight time of 
the vector (Aradaib et al., 1999). 
1.8.1. Prevention:-  
Pittman et al. (1999) stated that, to protect animals and 
humans from contracting RVF virus, a formalin-killed RVF virus 
vaccine (P-MKC) from monkey kidney cells infected with the 
pantropic strain of virus was developed. The prepared vaccine 
(NDBR-103) was evaluated in mice and hamsters for immune 
response and efficacy and for its immune response in humans. As 
applied technologies have been improved, a more modern 
inactivated product TSI-GSD-200 was developed and after 
successful preclinical evaluation tested in humans (Pittman et al., 
1999). The immunogenicity and safety profiles of TSI-GSD-200 are 
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excellent. The vaccine protects laboratory workers or others at high 
risk for RVF disease such as veterinarians in endemic areas. Booster 
injections can recall immunity lost after the primary series and can 
elicit antibodies in those with a sub-optimal response to the initial 
immunizations, Pittman et al., (1999).concluded, the use of TSI-
GSD-200 is safe and provides good long-term immunity in humans 
when the primary series and one boost are administered (Pittman et 
al., 1999). RVF vaccination is not recommended for the average 
traveler, but although it is not generally available, it may be 
indicated for those who are traveling to participate in international 
RVF-outbreak investigations or are otherwise at high risk of 
exposure (Isaacson, 2001).  
1.8.2. Control of RVF in Vertebrate Hosts:- 
              Immunization of susceptible animals is the most effective 
means for control of RVF (Meegan and Bailey, 1989). Two types of 
vaccines are currently used to immunize sheep and cattle in Africa. 
The attenuated live virus vaccine (Smithburn strain) is highly 
effective, but causes a small number of sheep to abort after 
immunization. It is relatively inexpensive and has been extensively 
used in endemic areas. Since there is a theoretical potential for 
reversion of the vaccine to virulence, it is not recommended for non-
endemic areas or for animals being exported from endemic areas 
(Meegan and Bailey, 1989). Formalin-inactivated vaccines have 
been used for many years in southern Africa, and recently in Egypt 
and Israel. These are safe and effective, but require multiple 
inoculations. This type of vaccine is recommended for non-endemic 
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areas or for animals being exported from endemic areas. Attenuated 
vaccine strains with several attenuation markers present in each 
genome segment should be considered as a safety measure for 
control of RVFV and to minimize the possibility of reversion to 
virulence (Sall et al., 1999).  
 An innovate subunit vaccine expressing the nucleocapsid 
protein, which is coded for by the small genome (S) genome, was 
recently evaluated in mosquito cells. The expressed recombinant 
antigen vaccine induced pathogen-specific resistance to RVFV in 
mosquito cells (Billecocoq et al., 2000).  In general, the subunit 
vaccine requires boostering and adjuvant to provide long lasting 
protective immunization (Aradaib et al., 1995).  The research on 
development of this subunit vaccine is in progress but the vaccine is 
not yet available for animal or human use. A broad-spectrum 
vaccine, which can protect against all RVFV strains, is yet to be 
developed. 
1.8.2.2. Quarantine Measure:- 
          Since enforcement of quarantine of animals is difficult in 
Africa, it is not generally an effective control measure. However, to 
whatever extent possible, movement of animals from epizootic 
situations should be restricted to prevent the further spread of RVF 
(Meegan and Bailey, 1989).  
1.8.3. Mosquitoes avoidance:-  
        A person's chances of becoming infected can be reduced by 
taking measures to decrease contact with mosquitoes and other 
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bloodsucking insects through the use of mosquito repellents and 
bednets (website 4)  
1.8.4. Avoidance of exposure to blood or tissues of animals:-  
          Avoiding exposure to blood or tissues of animals that may 
potentially be infected is an important protective measure for 
persons working with animals in RVF-endemic areas (website 4)  
         1.8.5. Treatment:-  
          Treatment is supportive and may require intensive care. Early 
diagnosis and supportive care can be lifesaving for most patients 
with VHF.(Anon.1988), The cornerstone of therapy for all these 
infections is judicious fluid and electrolyte management (website 3 
). Patients with RVF should be nursed in mosquito-protected 
premises (Isaacson, 2001). There is no established course of 
treatment for patients infected with RVF virus. However, studies in 
monkeys and other animals have shown promise for Ribavirin, an 
antiviral drug, for future use in humans. Additional studies suggest 
that interferon, immune modulators, and convalescent-phase plasma 
may also help in the treatment of patients with RVF (Website 2). 
1.9. Records of Epizootic or Infected Individuals:- 
           The attending clinician should report in a case summary form 
the information about the clinical signs of the disease, tentative 
diagnosis, prescribed medicine, and date of discharge as routinely 
done in humans and veterinary hospitals or clinics. If the patient 
died, postmortem findings and pathological lesion should be 
recorded, as they might be of significance in tentative diagnosis of 
RVFV infection. A similar procedure should be followed, if the 
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disease occurs in an epizootic form in animals and human 
populations. The place where the disease appears should be 
recorded. If an epizootic of hemorrhagic disease is suspected, 
notification of the authority would be the responsibility of the 
medical or veterinary officers in charge. 
 
          A collaborative scientific team should immediately conduct 
research investigation to implement hazard analysis and critical 
control point (HACCP) system to prevent further spread of the 
disease.RT-PCR would be advantageous for detection of an active 
RVFV infection within the same working day. Morbidity, mortality 
and case fatality rates are useful to estimate the economic 
significance of the epizootic. The season of the year is important for 
understanding the mode of transmission, where the vector density is 
usually very high in the rainy seasons.It should be considered that, 
overwintering transmission is common despite the fact that the 
activity of the invertebrate vectors is likely to be suppressed. This 
might help in identifying other reservoir hosts of the RVFV if the 
epizootic occurs in the winter. This information should be recorded 
and kept for future purposes.  
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CHAPTER TWO 
 
2-MATERIALS AND METHODS 
 
 2.1. Source of samples suspected RVF: 
       During September, 2002 an unusual heavy rainfall hit most 
regions of Sudan. This led to an increase in mosquitoes vectors. A 
febrile illness spread among cattle in Khartoum State; East Nile 
Province, in Almaigoma, Hillat Kuku, Abu Defiaea, Eid Babiker 
Babiker, Mahalab 1and 2, Alhaj Yousif (Fig.1) almost every locality 
in the Province was affected. Calves were severely affected with 
approximately 20-50% morbidity and in some herds, mortality 
reached almost 70%, Sheep exhibited less severe clinical signs. The 
disease incubation period was 3-7 days. Most of the pregnant 
animals aborted, and there was a sharp decrease in milk yield. In 
October the same year the disease extended to Khartoum South in 
Alshajara, military farm TaybaAlhassanab, Butry and Traiatalbija, 
with the same nature of high abortion rates and off-spring mortality. 
No mortality was recorded in mature animals. Clinical signs 
observed in diseased animals were salivation, nasal discharge, 
lacrimation, abortion, retained placenta, drop in milk production. In 
aborted feti there was enlargement of the head and abdomen. (Table 
.1). During this period, the same picture of the disease was reported 
in the River Nile State in Shendi, Alsayal, Aljiware and some other 
villages. In some farms there was malaria-like disease observed in 
humans who were in close contact with animals. By mid November 
the disease almost died out. 
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2.2. Study Design:- 
        Serosurveillance for RVFV antibodies was made during the 
year 2001, investigation of the suspected RVF outbreak in 
Khartoum and River Nile States was studied in the animals affected 
during 2002.   
2.3. Animal Sera:- 
         Sera were collected from cattle, goats and sheep from different 
geographic localities in the Sudan during 2001.They were obtained 
from the Department of Epizootics Control, Federal Ministry of 
Animal Resources and Fisheries. Other sera and diagnostic 
specimens (liver, spleen and lymph node from aborted fetuses) were  
collected from Khartoum, River Nile and White Nile states during 
2002and 2005 were also used in the study, sera were kept at -20 till 
used. 
2.4. RVFV Vaccine Strain (Smithburn):- 
         Smithburn live attenuated vaccine strain was imported from 
South Africa kindly donated to us by the Viral Vaccines 
Department, at the Central Veterinary Research Lab. (CVRL-Soba). 
2.5. Hemorrhagic RNA Viruses:- 
         Bluetongue virus (BTV), epizootic hemorrhagic disease virus 
(EHDV) and Crimean Congo hemorrhagic fever virus (CCHEV) 
RNAs were kindly provided by Prof Imad Aradaib, Department of 
Medicine Pharmacology and Toxicology, Faculty of Veterinary 
Medicine, University of Khartoum. 
2.6. African Green Monkey Kidney Cell (Vero cell):- 
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    Vero cells were kindly obtained from the viral vaccines 
Production Section (CVRLC), and used for the propagation of the 
vaccine strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.7. Detection of RVFV Antibodies and Antigen using different 
      Techniques includes:-  
2.7. 1. Indirect Sandwich ELISA: used for anti RVFV IgG detection 
2.7.2. Immunocapture ELISA: used for anti RVFV IgM detection    
2.7.3 Indirect ELISA: used for RVFV antigen detection.  
2.7.4. Indirect fluorescent antibody test (IFAT) 
 2.7.5. Reverse transcriptase polymerase chain reaction (RT-PCR)  
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2.7.1. Indirect Sandwich ELISA for the Detection of anti-RVFV 
IgG Antibody:- 
          Commercial ELISA kits for determination of RVFV IgG 
antibodies were purchased from the special pathogen unit, National 
institute for Virology, Johannesburg, South Africa .The ELISA is 
based on a sandwich format in which the plate was coated with 
mouse anti-RVF serum and then reacted with antigen. Test sera 
were applied and specific anti-RVFV IgG antibody was detected 
with an anti-species IgG HRPO conjugate and ABTS substrate. 
2.7.1.1 Chemicals used for Indirect Sandwich ELISA:- 
       Deionized distilled water(DDW), Phosphate buffered saline 
(PBS 0.01M PH 7.4), skimmed milk, Tween 20 (T20), washing 
buffer(PBS, 0.1% T20), blocking buffer( 10% skimmed milk in 
PBS) diluent buffer (2% skimmed milk in PBS). 2, 2-Azinodicthyl-
benzothiazoline sulfonic acid (ABTS) substrate, and Sodium 
dodecylsulphate (SDS) stop solutions. 
2.7.1.2. Biological reagents for Indirect Sandwich ELISA:-  
         Mouse anti-RVFV serum (coating antibody), RVFV antigen, 
control antigen, rabbit anti-sheep horseradish peroxidase (HRPO) 
conjugate, control sera: strong positive (C++), weak positive (C+) 
and negative control serum (C-). 
2.7.1.3. Test Procedure:- 
         The test was conducted as described by the manufacturers; all 
the solutions were prepared immediately before use. As shown in 
figure (2) the microtitre plate (Nunc maxisorp) was coated with 100 
µl /well anti- RVFV serum diluted 1:5000 in PBS (0.01M, Ph 7.4) 
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.The plate was covered with lid ,incubated at 4oC overnight, and 
then emptied, washed three times with washing buffer, then blocked 
with 200 µl/well skimmed blocking buffer, while being incubated in 
moist chamber at 37oC for 1hour. The plate was then emptied and 
again washed before 100 µl/well of RVFV antigen and control 
antigen diluted 1:400 in diluent buffer were added from A to D, 1-
12 rows and from E to H, 1-12 rows respectively .The plate was 
incubated then washed as described before 100 µl volumes of the 
control and tested sera freshly diluted 1:400 diluent buffer were then 
delivered into duplicate wells of the plate, Column 1 and 2 were 
used as control columns, while the rest of the plate for the tested 
sera .The plate was again incubated and washed. 100 µl/well Anti-
sheep IgG HRPO conjugate diluted 1:5000 in diluent buffer was 
added to all wells of the plate. Then the plate was incubated as 
described before, then washed 3 times.100 µl of ABTS substrate 
was then added to all wells and the plate was kept for 30 minutes in 
a dark place at room temperature. The reaction was then stopped by 
adding 100 µl/well of 0.1% Sodium dodecyl sulphate (SDS)) stop 
solutions.  The plate was read in Immunoskan (BDSL,United 
Kingdom) ELISA plate reader  using 405 nm filter. 
2.7.2. Immunocapture ELISA for the detection of anti-RVFV 
IgM  
       Antibody (BDSL-UK):- 
         Commercial ELISA kits for determination of RVFV IgM 
antibody were purchased from Biological Diagnostic Supplies 
(BDSL; United Kingdom). The ELISA is based on a capture format 
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in which the plates were coated with rabbit anti-sheep IgM capture 
antibody and then reacted with test sera.  Anti sheep capture 
antibody can be used for detection of IgM in sheep, goats and cattle. 
The captured IgM antibody was reacted with RVF antigen, and the 
bounded antigen was then detected with mouse anti-RVF antibody 
anti-mouse horseradish peroxidase (HRPO) conjugate plus ABTS 
substrate. 
2.7.2.1. Chemicals for Immunocapture (ELISA):- 
         Deionized distilled water(DDW)Phosphate buffered saline 
(PBS 0.01M PH 7.4), skimmed milk, Tween 20 (T20), washing 
buffer(PBS, 0.1% T20), blocking buffer( 10% skimmed milk in 
PBS) diluent buffer (2% skimmed milk in PBS) 2, 2-Azinodicthyl-
benzothiazoline sulfonic acid (ABTS) substrate, and Sodium 
dodecylsulphate (SDS) stop solutions. 
2.7.2.2. Biological reagents for Immunocapture ELISA:- 
          Rabbit anti sheep IgM, RVFV antigen, control antigen mouse 
anti-RVFV serum, Goat anti-mouse IgG horse-radish peroxidase 
(HRPO) conjugate, control sera: strong positive (C++), weak 
positive (C+) and negative control (C-) 
2.7.2.3. Test procedure:- 
       The test was performed according to the manufacturers 
protocol, all the solutions were prepared immediately before use as 
shown in figure.3.the microtitre plate (Nunc Maxisorp) was coated 
with 100 µl /well RVFV rabbit anti-sheep IgM diluted 1:2000 in 
PBS .The plate was incubated at 4oC overnight, emptied and washed 
three times with washing buffer, then blocked with 200 µl /well 
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blocking buffer and incubated in moist chamber at 37oC for hour. 
The plate was then emptied and again washed as before. 100 µl 
volumes of the control and tested sera freshly diluted 1:400 in 
diluent buffer,were delivered into duplicate wells of the plate, 
Columns 1 and 2 were used as control columns, while the rest of the 
plate was used  for the test sera .The plate was again incubated and 
washed as previously described. 100 µl/well of RVFV antigen and 
control antigen freshly diluted 1:400 in diluent buffer were added 
from A to D. 1-12 rows and from E to H, 1-12 rows respectively.  
The plate was incubated again, then washed as above, 100 µl of 
Mouse anti-RVFV serum diluted 1:500 in diluent buffer was added 
to each well, The plate was incubated for 1 hour and then washed, 
100µl/well anti-mouse IgG horseradish peroxidase (HRPO) 
conjugate freshly diluted 1:4000 in diluent buffer was added to all 
the plate, another incubation was done as described before, then 
emptied and washed again, 100 µl of ABTS substrate were added to 
all wells and the plate left for 30 minutes in a dark place at room 
temperature. The reaction was then stopped by adding 100 µl/well 
of 0.1% Sodium dodecyl sulphate (SDS)) stop solutions.The plate 
was read in Immunoskan (BDSL, United Kingdom) ELISA plate 
reader using 405 nm filter. 
 
2.7.3. Indirect ELISA for detection of RVFV antigen:- 
    This ELISA was formulated and developed at CVRL to detect 
RVF antigen from suspected tissue samples and sera collected 
during the period of 2002. The ELISA is based on indirect way in 
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which the plate was coated with RVF Ag which was then reacted 
with mouse anti- RVFV antibody and anti-species IgG HRPO 
conjugated and ABTS. 
2.7.3.1. Chemicals used for Indirect ELISA:- 
          Deionized distilled water(DDW) Phosphate buffered saline 
(PBS 0.01M PH 7.4), skimmed milk, Tween 20 (T20), washing 
buffer(PBS, 0.1% T20), blocking buffer( 10% skimmed milk in 
PBS) diluent buffer (2% skimmed milk in PBS) 2, 2-Azinodicthyl-
benzothiazoline sulfonic acid (ABTS) substrate, and Sodium 
dodecylsulphate (SDS) stop solutions. 
2.7.3.2. Biological reagents used for Indirect ELISA:- 
          RVFV antigen, control antigen, Mouse anti-RVFV serum, 
Anti-mouse IgG horseradish peroxidase (HRPO) conjugate, all of 
these reagents were obtained from the Biological Diagnostic 
Supplies Ltd. (BDSL) United Kingdom (UK) 
2.7.3.3. Test procedure:- 
          All the solutions were prepared immediately before use as 
shown in figure .4. The microtitre plate (Nunc Maxisorp) was 
coated with RVFV Ag diluted 1:400 in diluent buffer, columns 1 
and 2 were used as control Ag from A to B for the known +ve Ag 
and from C to D for the known –ve Ag.  The rest of the plate was 
used  for the samples, (from 1-8 serum samples, 9-12 tissue 
samples, liver and spleen from the oozing fluids), the plate was 
covered with lid, incubated for 1 hour in moist chamber then 
washed as described above  for both ELISA.  100µl/well Mouse anti 
RVFV serum diluted 1:500 in diluent buffer were added.  The plate 
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was incubated then washed. Anti-mouse IgG HRPO conjugate 
diluted 1:4000 in diluent buffer were added to all the plate at the 
rate of 100µl/well. The plate was incubated in moist chamber at 
37oC for 1 hour, and then washed as described before. 100µl of 
ABTS substrate were added to all wells then the plate was left for 
30 minutes in a dark place at room temperature. The reaction was 
then stopped by adding 100 µl/well of 0.1% Sodium dodecyl 
sulphate (SDS)) stop solutions. The plate was read in Immunoskan 
(BDSL) ELISA plate reader using 405nm filter. 
 
 
 
             
 
 
 
 
 
 
 
 
 
 
 
 
 
 66
 
 
  Figure.2. Indirect Sandwich ELISA for the Detection of  
 Anti-RVFV IgG antibody. Plate layout 
       
         1       2        3     4      5      6     7     8      9     10    11    12 
A C++ C++ 1 5 9 13 17 21 25 29 33 37 
B C++ C++ 2 6 10 14 18 22 26 30 34 38 
C C+ C+ 3 7 11 15 19 23 27 31 35 39 
D C- C- 4 8 12 16 20 24 28 32 36 40 
E C++ C++ 1 5 9 13 17 21 25 29 33 37 
F C++ C++ 2 6 10 14 18 22 26 30 34 38 
G C+  C+  3 7 11 15 19 23 27 31 35 39 
H C- C- 4 8 12 16 20 24 28 32 36 40 
                                                  
C++: Strong control positive serum  
C+   : Weak control positive serum  
C-    : Negative control serum  
           1-40 test sera  
           Rows A-D 1-12 RVFV Ag 
           Rows E-H 1-12 Control Ag 
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       Figure .3.Immunocapture ELISA for the detection of  
                 Anti-RVFV IgM antibody Plate layout 
   1   2 3   4  5  6  7 8  9 10 11 12 
A C++ C++ 1 5 9 13 17 21 25 29 33 37 
B C++ C++ 2 6 10 14 18 22 26 30 34 38 
C C+ C+ 3 7 11 15 19 23 27 31 35 39 
D C- C- 4 8 12 16 20 24 28 32 36 40 
E C++ C++ 1 5 9 13 17 21 25 29 33 37 
F C++ C++ 2 6 10 14 18 22 26 30 34 38 
G C+  C+  3 7 11 15 19 23 27 31 35 39 
H C- C- 4 8 12 16 20 24 28 32 36 40 
                                     
       C++: Strong control positive serum  
       C+   : Weak control positive serum  
       C-    : Negative control serum  
               1-40 test sera  
               Rows A-D 1-12 RVFV Ag 
               Rows E-H 1-12 Control Ag  
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  Figure.4. Indirect ELISA for detection of RVFV antigen 
         Plate layout   
        
 1 2 3 4 5 6 7 8 9 10 11 12 
A Ag++ Ag++ 5 5         
B Ag++ Ag++ 6 6         
C Ag- Ag- 7 7         
D Ag- Ag- 8 8         
E 1 1 9 9         
F 2 2 10 10         
G 3 3 11 11         
H 4 4 12 12         
                                                      
++Ag:  Positive control antigen  
-Ag    : Negative control antigen   
 1-12  :  Test samples 
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2.7.4. Indirect fluorescent Antibody (IFA) test:‐ 
2.7.4.1. Chemicals used for (IFA) test:- 
          Deionized distilled water (DDW), Phosphate buffered saline 
(PBS 0.01M PH 7.2), Tris buffer, pH 7.4 acetone (Analar), glycerol 
mounting media and fluorescein-isothiocyanate (FITC). 
2.7.4.2. Biological reagents used for (IFA) test:- 
         RVFV vaccine strain(Smithburn), fetal calf serum (FCS), 
(Sigma USA),rabbit anti-bovine IgG antibody conjugated to FITC, 
positive and negative  RVFV control sera and test sera.     
  2.7.4.3. Antigen slides preparation:‐ 
        In brief flask cultures of Vero cells were infected with RVF 
vaccine strain (Smithburn) and the cells were harvested by 
trypsinization 60 hours post infection at an early stage of cytopathic 
effect(CPE). The cells were centrifuged at 800 g for 5 minutes and 
resuspended at 106/ml in tris-buffered saline, pH 7.4, containing 5% 
fetal calf serum (FCS). The cells were held at 4oC overnight, washed 
and resuspended at 106/ml in isotonic saline with 5% FCS. Spots 
were prepared from 0.01ml volumes of cell suspension on 8-well 
Teflon-template microscope slides (Highveld Biological 
(PTY).LTD, Lyndhurst, RSA). This was done by pipetting 0.01ml 
of the suspension into a well and immediately aspirating the excess 
and transferring it to the next well using single channel 
micropipette. The slides were allowed to air-dry, fixed in ice cold 
acetone for 10 minutes and again air-dried, and then they were 
individually wrapped in tissue paper and packed in aluminum foil 
with 5 slides in each packet. These   packets were labeled indicating 
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numbers and date of the preparation of the slides, and then stored at-
80oC until used. 
 2.7.4.4. Conjugate:‐ 
          Rabbit anti-bovine IgG conjugated to FITC was kindly 
obtained from the department of ticks and tick borne disease in 0.1 
ml a liquot. 
2.7.4.5. Dilution of the Conjugate:‐ 
           An aliquot of (0.1 ml) of the conjugate was thawed at room 
temperature and diluted 1:20 in PBS pH 7.2. Evans blue (50 µl) at a 
concentration of 0.1% was added to the conjugate as a counterstain 
in order to improve the definition of specific fluorescence.   
 2.7.4.6. Control sera:- 
        The positive and negative control sera were provided in the 
ELISA kit as mentioned before.               
 2.7.4.7. Dilution of the tested sera:- 
       Bovine sera collected from the field were allowed to thaw at 
room temperature,and then arranged in numerical order in a rack; 
sera were diluted 1:10 dilution in PBS, pH 7.2. 
2.7.4.8. Thawing of the antigen slides:- 
        Antigen slides were allowed to thaw at 4 oC for 30 minutes then 
placed at room temperature for another 30 minutes before they were 
unwrapped and labeled with location and tested sera numbers. 
2.7.4.9. Test procedure:- 
        The test was conducted as described by (Swanepoel et al., 
(1986) with slight modification, the antigen slides once thawed and 
labeled were placed in Petri dishes on a moist filter paper. To each 
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slide 2oµl of C +ve and C -ve sera were added to the well 6 and well 
12 respectively, the tested sera were added to the rest of the wells  
by adding 20µl diluted sera using a single micropipette (Fig.5.). A 
clean tip was used for each tested serum sample. The slides were 
incubated in a moist chamber at 37 oC for 30 minutes to allow 
antigen/antibody reaction, the slides were washed three times, 10 
minutes each in stirred PBS, pH 7.2.The buffer being renewed after 
each 10 minutes, and then the slides were held inverted onto a filter 
paper for excess PBS to drain. The slides were replaced in a Petri-
dish and 10µl of the diluted conjugate was applied to each well and 
allowed to react for                     
a further 30 minutes at 37oC in moist chamber, again the slides were 
washed as described above, dried and prepared with glycerol 
mounting medium and cover-slip for examination on an indirect-
light fluorescent microscope in a dark room.  
 
 
 
 
 
 
         Figure.5. Diagrammatic representation of multi-spot                 
slide showing the positions of the controls and tested sera 
 
 
 
Label  1 2 3 4 5 6  C+ve 
A1 7 8 9 10 11 12 C-ve 
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2.7.5. Reverse transcriptase polymerase chain reaction (RT-PCR): 
         Single tube reverse transcriptase polymerase chain reaction 
(RT-PCR) method focusing on the NSs coding region of the S 
segment was developed and used to detect the RVF virus (RVFV) 
genome. 
2.7.5.1 Chemicals and Reagents for RT-PCR:- 
         QIA amp viral RNA extraction kit contains the following: 
lyophilized carrier RNA, AVL buffer, pure ethanol, AWI, AW2 
washing buffers, and AVE lyses buffer. Single tube RT-PCR kit 
contains: 5x reaction buffer, 5Mm dNTP mix, pH 7.5 with dATP, 
dCTP, dGTP, dTTP. Enzyme mix (Taq-DNA-Polymerase+Rnase 
Inhibitor), RVFV Primers and ddH2O. 
2.7.5.2. Extraction of Viral RNA:-  
 Extraction of viral nucleic acid was carried out by the QIA amp 
RNA extraction kit (QIA GEN GmbH, Hilden, Germany).As 
described by the manufacturers. RNAs were extracted from 
supernatant of Vero cell culture infected with RVFV vaccine strain 
(Smithburn) and homogenate from aborted feti tissue samples as 
follows; 
a)  The lyophilized carrier RNA was dissolved in 1ml AVL buffer 
and transferred to the AVL bottle and mixed thoroughly .Five 
hundred and sixty (560) µl from this preparation were dispensed in 
each 1.5ml micro centrifuge tube and kept at 4oC, till used. 
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b) All samples and reagents were equilibrated to room temperature 
before use.  
(c) 140 µl medium from Vero cell culture infected by RVFV 
vaccine strain (Smithburn) and homogenate from aborted feti tissue 
samples were added to the buffer AVL containing carrier RNA and 
mixed by pulse vortexing for 15 seconds. 
(d) The mixture was left for 10 minutes at room temperature. 
(e) The tubes were then spun briefly to clean the lid. 
(f) 560 µl of pure ethanol was added and mixed by pulse   vortexing 
for 15 seconds and spinning briefly. 
(g) 630µl from the mixture were applied in the QIA amp spin 
column and assembled in a 2ml collection tube then centrifuged at 
8000 rpm for 1 minute. 
(h) The columns were transferred to another collection tubes; the 
remaining 630µl of the mixture was applied and centrifuged at 8000 
rpm for 1 minute again. 
(i)  500µl of buffer AWI was added to the columns and centrifuged 
at 8000 rpm for 1 minute.  Another 500µl of wash buffer AW2 was 
added and centrifuged at 14000 rpm for 3 minutes. 
(j)  The spin column were transferred to 1.5 ml micro centrifuge 
tubes and loaded with 60µl of buffer AVE to elute the viral RNA.  It 
was centrifuged at 8000 rpm for 1 minute.  The tubes containing 
RNAs were labeled and kept at –20oC till used. 
2.7.5.3. Primers:- 
 The primers were kindly donated by Prof. Gerrit J.Viljoin, S. Africa  
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These primers were flanking 363bp regions in the S segment of the 
RVFV genome. Forward:5'-ATGCTGGGAAGTGATGAGAGCG-
3' 
                          Reverse:  5'-GATTTGCAGAGTGGTCGTC-3'  
2.7.5.4. Reverse transcriptase polymerase chain reaction (RT-
PCR) 
         The amplification was performed using peqlab single tube RT-
PCR kit (GmbH,Germany). The following components were mixed 
in a PCR reaction tube: 5 µl total RNA, 5µl 5x reaction buffers, 
2.5µl 5mMdNTP mix, 2µl primers and 1µ1enzyme mix. The final 
volume was then completed with ddH2O to 25µl. The components 
were mixed thoroughly by vortexing and centrifuged at 8000 rpm 
for 1 minute. The RT-PCR was performed in Techne PHC-2 
thermal cycler (Techne, Princeton, NJ, USA).  Initial transcription 
step was done at 42oC for 30minutes followed by 35 cycles of 
amplification.  Each cycle include denaturation at 95oC for 10 
minutes, annealing at 65oC for 5 minutes and extension at 72oC at 5 
minutes. 
2.7.5.5. Agarose gel electrophoresis:- 
           Following RT-PCR, 15µl of the total reaction volume were 
added to 5µl of Bromophenol blue dye, loaded to 1% agarose gel 
and then submerged  in Tris Borate EDTA (1X TBE) running buffer 
containing 0.001% Ethedium bromide(50mg/ml).2 µl DNA 
molecular weight marker 1kbp ladder was run in a parallel well. 
Constant electric current of 80 MV for about 45 minutes was 
applied. 
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2.7.5.6. Sensitivity of the RT-PCR:- 
To determine the minimal amount of the RVFV vaccine strain that 
can be detected using simple RT-PCR, the extracted RNA was 
serially diluted in ddH2O ranging from 10-1 to 10-6 and one tube was 
kept with master mix alone i.e. without RNA as negative control. 
All the tubes were amplified except the control one, as mentioned 
before and applied on agarose gel.  
 2.7.5.7. Specificity of the RT-PCR:- 
  The specificity of the (RVF) virus primers was tested with 
other hemorrhagic viruses like, bluetongue virus (BTV), epizootic 
hemorrhagic disease virus (EHDV) and Crimean Congo 
hemorrhagic fever virus (CCHFV). Viral RNAs were amplified by 
single tube RT-PCR and analyzed in agarose gels. 
2.8. Entomological Study:-   
         Part of this work was conducted at the general Administration 
of Malaria Control, Ministry of Health, Department of Medical 
Entomology, National Health laboratory and the CVRL.  
    Two types of collection were carried out: 
 1. Larval collection method or dipping collection method for 
aquatic stages of mosquitoes. Twenty dips were taken at regular 
intervals from fixed productive sites of mosquitoes from March till 
November 2002 in Khartoum State. Collected larvae were 
transferred into plastic containers and protected to minimize 
shaking. 
 2. Adults collection: two methods were used for collecting adults 
mosquitoes indoor spray collection and aspiration collection 
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methods. In the laboratory, the fourth instar larvae were separated 
from other stages counted and prepare for identification. For 
preparation of larval mounts, the larvae were killed in warm water 
then dehydrated in 70% ethyl alcohol followed by 5 minutes in each 
80%, 90% and absolute alcohol, Abugroon et al. (1988).       
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CHAPTER THREE 
 
3. RESULTS 
 
3.1. Detection of RVF antibodies:-  
3.1.1. IgG ELISA:- 
A total of 1351 sera (491 bovine ,423,ovine and 437 caprine) 
from different regions were screened for RVF IgG antibodies at  
1/100 dilutions .Out of these ,15 (3.55%) ovine sera ,and 1 (0.25%) 
caprine serum were positive while none of the bovine samples tested 
positive (Fig.7.). The overall prevalence rate was 1.2%. The 
prevalence rate of suspected RVF IgG antibodies in sheep ranged 
from 10% in Shendi (River Nile State) to 3.4% in Buram (Southern 
Darfur State). The one goat serum found to be positive was from 
Gedarif State. 
3.1.2. IgM ELISA:- 
A total of 1543 serum samples collected from three different 
animal  species ( 618 from bovine ,612 from ovine and 313 from 
caprine ) from different regions(Northern, eastern, western and 
central Sudan ), were screened for RVF IgM antibodies at 1/100 
dilutions, no positive results were recorded as shown in Table .2.and 
fig.8.  During 2002, 107 bovine serum samples were tested for RVF 
IgM antibodies, 31(28.97%) out of these were found positive, 
(Fig.6.) Compared to 9(2.7%) serum samples from 410 serum 
samples from the same species collected during 2005, (Fig.11). 
 78
The prevalence rate was found to be 21.1% and 70.5%among 
bovine samples collected from Khartoum and Shandi respectively 
during 2002. As shown in (Fig.10.), RVF IgM antibodies were not 
detected among serum samples collected from both ovine and 
caprine species. No clinical cases were reported during 
2003.Moreover all the positive reactors during 2002 were culled or 
removed from the herds.   
3.1.3. Antigen Detection ELISA:- 
          Four tissue samples and eight sera were screened for RVF 
antigen using Indirect ELISA. Two tissues liver and spleen were 
positive, showing intense color development while the three serum 
samples were faint.    
3.2. Results of IFA test:- 
          100 bovine serum samples collected from different locations 
in Khartoum were tested for RVF antibodies using IFA test, of 
which 31amples were positive for IgM ELISA. Twenty three 
samples were positive with IFA test; in comparison with ELISA this 
test was slightly less sensitive and less specific in detecting RVF 
antibodies.    
3.3. Development of the detection methods:- 
          Two steps for RT-PCR were tested initial transcription step    
followed by 35 cycles of amplification. Analysis of the RT-PCR 
products in agarose gel and staining with promphenol blue revealed 
the presence of the expected bands of the 363 bp obtained from 
RVFV vaccine strain and two homogenate of spleen and liver 
samples of aborted feti RNAs extracts (Fig.12.). 
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3.4. Sensitivity of the RT-PCR:- 
          The RT-PCR method is a sensitive test for detection of RVF 
virus even if a minimal amount of viral RNA is present (Fig.13.). 
3.5. Specificity of the RT-PCR:- 
RT-PCR product was not detected when RNA samples from 
BTV, EHDV and CCHF were applied; this indicate that the primers 
did not amplify any region in the genome of these viruses and this 
show the   specificity of this system for RVFV(Fig.14.). 
3.6. Species Composition:- 
          Culicine mosquitoes accounted for 78.4% and anopheline for 
21.6%.  Culex quinquefasciatus alone accounted for 81.9% of the 
mosquitoes of the genus in the capital towns and suburb while 
Anopheles arabiensis, the main malaria vector in the area 
contributed about 97.2% of the genus Anopheles. Among the three 
cities of the capital Khartoum sustained more species than 
Khartoum North and Omdurman. In the year 2001 a total of 4353 
larvae were collected by dipping method and a total of 725 adults 
mosquitoes were identified. In the year 2005, a total of 3372 
Anopheles and 853 Culex larvae were collected, all these species of 
mosquitoes transmit RVFV even anophelines the vector of malaria 
parasite plasmodium it causes rupture of the salivary glands of the 
mosquitoes and then facilitate transmission of the RVF virus.       
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Table (1) Shows the locality and abortion rates in some 
examined cattle herds in Khartoum State during the year 2002  
Locality No of animals 
examined 
Age of 
aborted 
feti/months
Abortion 
rates  
Type of samples 
collected 
Almaigom
a  
65 5-9 40% Whole blood, liver 
,vaginal  
Swap and spleen   
AlhajYosif 80 5-8 20-45% Whole blood, vaginal 
swap and liver  
Mahalab 2 100 5-7 40% Whole blood, vaginal 
swap ,liver and spleen 
Alshajara 200 5-9 40% Whole blood ,liver and 
spleen   
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 Figure.6. Showed the locality and abortion rates in some 
examined cattle herds in Khartoum State during the year 2002  
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              Table .2. Result of IgM ELISA during 2001 
 
Locality Animal 
species 
Total No. of 
+ve (%) 
River Nile  Ovine 50 - 
 Caprine 35 - 
 Bovine 70 - 
Kassala Ovine 40 - 
 Caprine 25 - 
 Bovine 30 - 
Red Sea Ovine 49 - 
 Caprine 60 - 
 Bovine 57 - 
S. Darfur Ovine 86 - 
 Caprine 38 - 
 Bovine 70 - 
W. Kordofan Ovine 100 - 
 Bovine 79 - 
Khartoum Ovine 40 - 
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 Caprine 30 - 
 Bovine 
 
80 - 
Omdurman Ovine 45 - 
 Bovine 30 - 
E. Nile Ovine 50 - 
 Caprine 80 - 
 Bovine 45 - 
White Nile  Ovine 80 - 
  Bovine 75 - 
Blue Nile Ovine 78 - 
 Caprine 45 - 
 Bovine 76 - 
 85
0
20
40
60
80
100
120
- - - - - - - - - - - - - - - - - - - - - - - - - - -
50 35 70 40 25 30 49 60 57 86 38 70 100 79 40 30 80 45 30 50 80 45 80 75 78 45 76
Ovine Caprine Bovine Ovine Caprine Bovine Ovine Caprine Bovine Ovine Caprine Bovine Ovine Bovine Ovine Caprine Bovine Ovine Bovine Ovine Caprine Bovine Ovine Bovine Ovine Caprine Bovine
River Nile Kassala Red Sea S. Darfur W. Kordofan Khartoum Omdurman E. Nile White Nile Blue Nile
No. of –ve (%)
 
            Figure.8. Result of IgM ELISA 2001 
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Figure .10. Overall results for IgM ELISA during the year 2002 
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                        Figure.12. Detection of 363 bp specific RVFV PCR 
                         Product using RT-PCR from clinical samples 
                              M= Molecular weight marker (100bp ladder) 
                               1= RVFV Vaccine Strain (Smithburn) as positive control. 
                              2=RNA extracted from non infected Vero cell negative control              
3= RNA extracted from serum sample. 
                                 4= RNA extracted from spleen of aborted fetus  
                                 5, 6, 7 RNAs extracted from serum samples. 
                                 8= RNA extracted from liver of aborted fetus      
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                              Figure. 13. Sensitivity of amplification of RVFV genomic RNA 
                                      M= Molecular weight marker (100bp ladder) 
                                 1 -6 serial dilutions RVFV genomic RNA extracted from        
Vero cell infected with the vaccine strain (Smithburn)  
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Mw 2 3 4 5  6  
                                            
                                                                                           
   Figure.14. Specificity of RT-PCR for RVFV Genomic                           
                                           RNA extracted from cell culture Infected                                           
                                                 With the vaccine strain (Smithburn). 
                                          Mw= Molecular weight marker (100bp ladder) 
                                          2= Rift Valley Fever Virus vaccine strain (Smithburn)  
                                          3= Epizootic hemorrhagic disease virus (EHDV) 
                                        4= Bluetongue Virus. (BTV)  
                                        5= Crimean Congo hemorrhagic fever virus. (CCHFV)  
                                       6= RNA extracted from non infected vero cell as control.                                 
The 363 bp PCR amplification product was detected only with RVFV RNA.     
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CHAPTER FOUR 
 
DISCUSSION 
 
              Rift Valley Fever (RVF) is an arboviral disease transmitted by 
mosquitoes; it affects primarily ruminants causing high mortality in off-
spring and abortions in pregnant females. The disease occasionally 
affects humans, with clinical picture that ranges from a mild febrile case 
to hemorrhagic fever with complications such as hepatitis and retinitis 
(Laughlin et al., 1979).  
          Epidemics of RVF in Southern Africa occur in 5-10 years cycles, 
but in dry semiarid zones of Eastern Africa the periodicity is 15-30 years. 
During prolonged droughts RVF virus may entirely disappear from large 
areas due to death of reservoir drought-resistant mosquitoes (FAO, 
1995). 
          The disease was previously reported in Sudan based on serological 
survey that indicated presence of antibodies to RVF virus in animals and 
human sera, (Findlay, 1936, Eisa et al., 1977, 1980, 1984, Watts et al., 
1994, and Kambal, 1997) From all the data collected by aforementioned 
authors, it seems that RVF was prevalent in subclinical form, but the lack 
or poor of reporting system of the clinical cases did not reflect the real 
situation, because indigenous animals may not show clinical signs due to 
innate resistance, (FAO, 2002). The virus activity may be revealed by 
random isolations from mosquitoes or by occasional human disease, 
(FAO, 2002). 
 
 94
                        Many serological tests were used for diagnosis of RVF such as 
hemagglutination inhibition, complement fixation; agar gel           
immunodiffusion and neutralization test (Meegan et al, 1989).        These 
methods were replaced by IgM antibody-capture or antigen-capture 
ELISA (Peters et al., 1989). ELISA test has been developed with an 
inactivated viral antigen to provide safe and highly accurate alternate so 
it has the advantages over serum neutralization test which is specific and 
sensitive but time consuming and constitutes hazard to the laboratory 
diagnosticians as it requires the use of live virus (Swanepool and 
Coetzer, 1994) found that; ELISA was sensitive and specific in detecting 
RVF viral antibodies in comparison with plaque reduction neutralization 
test (PRNT). Similarly, Niklasson et al., (1984) found a close correlation 
between ELISA and PRNT in detecting RVF viral antibodies in serum 
samples from human RVF vaccinees. Moreover, serum neutralization 
and PRNT were not recommended for use outside endemic countries 
unless a high level of biocontainment was available in laboratories.  In 
addition the IgG and IgM ELISA were sensitive tests. There was no 
evidence of serological cross reactivity of RVF with other African 
pheleboviviruses which could obscure the diagnosis of RVF (Swanepool 
and Coetzer, 1994), also ELISA can detect earliest immunological 
responses to infection with RVFV and this is in agreement with Paweska 
et al., (2003) who found the sensitivity of both ELISA (IgG and IgM) 
99.05% to 100% and from 99.1% to 99.9% respectively. It was also 
stated that; detection of IgM by ELISA was a reliable marker of 
infection. Antibodies appear 5 to 14 days after onset and coincided with 
clinical improvement (Peter. 2005).The overall prevalence rate of IgG 
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antibody during the year 2001 was ranging from 3.4% to 10% in animals 
from Buram (Western Sudan) and Shandi (Northern Sudan) respectively. 
These foci (Shandi and Buram) of RVF may present a hazard when 
suitable environmental conditions prevail, when modifications in the 
ecology, biology of the virus and environmental conditions appear to be 
conducive to the emergence of the disease outbreaks, (Meegan and 
Bailey., 1989; Peters et al., 1994). No IgM antibody was detected during 
2001in all sera tested. 
        The overall results obtained in this study were in contrast with that 
reported by Eisa, (1984) who stated widespread and high prevalence of 
RVFV antibodies in Sudanese livestock. This may be due to the drought 
and desertification that occurred in Sudan since mid 80s have  led to the 
disappearance of the virus from most of the infected areas in Sudan and 
limited virus distribution to localized foci. The illegal deforestation in the 
rich savanna area may also lead to the disappearance of the reservoir 
hosts. 
          In July 2002 there was an unusually heavy rainfall and flooding 
that persisted for three months and this led to increase in vectors 
populations. In August 2002 a pyrexic disease spread among cattle in 
every locality in Khartoum and River Nile states manifested in high 
abortion rates reaching up to 70% and deaths of aborted feti. This raised 
the suspicions of RVF outbreak,  
          Following the spread of the disease a field survey was carried out to 
investigate and diagnose the condition, the overall prevalence rate of 
anti-RVFV IgM antibody was 28.9% among animals in the two states. 
This is quite similar to that reported by Eisa et al in 1977 and 1980 who 
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stated that a febrile illness spread among cattle in the Kuku dairy farm, 
calves were severely affected experiencing 40% mortality and 100% 
morbidity. This is in agreement with the fact that cattle usually show the 
highest prevalence of antibodies (65-95%) during RVF outbreaks (FAO, 
2002). 
          In some of the sera tested during 2002, the optical density (OD) 
value of the negative control antigen well, was  higher than for the 
positive antigen; this means that this serum sample may contain antigen 
i.e. the blood sample was taken during the acute phase of the disease 
(viraemic blood ). This was later proved using the direct ELISA for Ag 
detection.   
          Antigen detection by antigen-capture ELISA performed on serum or 
other samples (tissues of aborted feti) can be used to detect most 
hemorrhagic fever viruses, (Ksiazek, 1992; Towner, 2004).   
          In this study detection of RVFV antigen was tried by Ag capture 
ELISA using tissues (Liver, Spleen and brain) and serum samples, from 
aborted feti; tissues gave obvious color development while 3 serum 
samples were positive with lesser color intensity development.  
          IFA test has certain advantages as a serological technique, as it 
detects antibody response at an early stage and demonstrates antibody at 
high levels comparable to any other techniques. Moreover, antigen slides 
can be stored frozen, ready for immediate use; results can be obtained in 
about an hour. Sheep and cattle have a tendency to produce non-specific 
fluorescence of control cells at low dilutions (Swanepoel. et al, 1983). 
IFA test can also be used to detect viral antigen directly in impression 
smears of tissues of RVF-infected animals, particularly liver or fetal 
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brain ((Swanepoel et al, 1986). In this study IFA test was tried for the 
diagnosis of RVF antibodies. 23 out of 100 bovine serum samples show 
obvious fluorescence, 
          In comparison, ELISA and IFA tests were technically simpler than 
neutralization method because the latter requires high containment 
facilities. However, the reagents were relatively easy to obtain. IFA is 
very subjective, results may vary between observers. Since ELISA 
reagents are of high quality, it appears to be a precise and technically 
feasible method for detecting RVFV antibodies. The degree of agreement 
between the two tests (92%) is high enough to the IFA test to be used for 
the diagnosis of RVF infection.      
          Molecular techniques have also been applied for the detection of 
RVFV nucleic acid.  Hybridization assay exhibitited low sensitivity 
(Knauert et al., 1989) and RT-PCR was successfully used to detect 
RVFV infected mosquitoes (Ibrahim et al., 1997). In our study RT-PCR 
was used successfully to detect RVFV vaccine strain (Smithburn) 
propagated in Vero cells tissue culture and in tissues from aborted foeti. 
It was specific, sensitive, rapid, and easy to perform. RT-PCR product 
was not detected when RNA samples from BTV, EHDV and CCHF were 
applied to this RT-PCR. Also the single tube procedure reduced 
drastically the potential risk of contamination. Moreover, the detection 
limit of the RT-PCR appeared to be very low and might be useful for 
testing samples with very low viraemia, (Sall et al., 2001). Despite some 
limitations in terms of its sensitivity, its cost and the level of expertise 
required of technicians, RT-PCR method is a rapid, sensitive, specific 
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and reliable assay for early detection of RVF infection even minimal 
amount of viral RNA is present,(Sall et al., 2001). 
   It should be used routinely in conjunction with IgM ELISA for 
early diagnosis of suspected cases of RVF infection. 
        Mosquitoes remain one of the most important groups of insects 
which transmit a number of fatal diseases one of them is RVF. 
          Abugroon, et al (1988) stated that during mosquito Population 
Studies in the three towns of the capital of the Sudan, nine culicine 
species were encountered.  Cx. Quinquefasciatus and Cx. Univittatus 
were most dominant and widely distributed species of the genus Culex. 
The study also showed a localized occurrence of aedes eagupti and aedes 
Caspuis. Anopheles arabiensis and Anopheles pharoensis were the only 
anopheline species found in the area. 
          Hussien (2002).stated that the most commonly used tool for 
collecting larvae were the dippers, which vary in size and shape but 
should always be white in color to facilitate collection of larvae. 
anophelines, aedines and some culicines were reported, the dominant 
species of Anopheline Mosquitoes was An. Arbiensis. Population density 
of An. Arbiensis was recorded during all months of the years except in 
May.  Two peaks were observed, the major peak being the end of the 
rainy season (September, October) and the minor one at winter time 
(December, January). (Hussein, 2002). 
 A general survey was conducted in July 2005 which covered all 
Khartoum State, mosquitoes were collected from the following areas: 
Soba Gharp, Soba Sharg, Rimaila, AlShigailab,  Jabra, Burri,  AboSieid, 
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Arkaweet, Al Gamair, Alban koko, IdBabikir, Dal Company project, 
AlGezeira, Dar AlSalaam, AlSarha and  AlGaily. 
   The higher densities were reported in AlShigailab 11.6%, Soba 
Gharp 11%, Soba Sharq 99%, Burri 8 % and  Arkweet 7%.The 
Anopheles species identified were: Anopheles arabiensis which is mainly 
breed in the domestic habitat. Anopheles phrensis collected mainly from 
farming areas. A total of 853 Culex larvae were collected from the above 
mentioned Stations mainly from contaminated water in farms and 
domestic habitat. Aedes mosquitoes have not been found in Khartoum so 
far. Cx. Quinquefasciatus had become most dominant because of its 
ability to exploit the range of breeding water available specially the 
highly polluted ones. It breeds in irrigated canals open drains septic tanks 
soakage pits small ditches, rain pools foot and hoof prints and metallic 
and other water containers.  According to Emile (1986) the species can 
utilized all types of habitats created through urban growth. It was even 
more dominant than An. Arabiensis which has greater temperature 
endurance as reported by Omer and Cloudsley (1968).  El Rayah and 
Nawal (1983). 
 Cx. Quinquefasciatus together with the other species newly 
reported in the area seems to have been introduced in the last decade as a 
result of urban growth and lack of control measures.  Cx. Antennatus and 
Cx. Pefuscus which favours small grassy ditches are now spread with 
intensive agriculture. An. Pharoensis frequent in Gazera scheme might 
have reached Khartoum with the Managil branch which waters the green 
belt (12km from Khartoum). 
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 An. Arabiensis, the main malaria vector in Central Sudan is 
reported in this survey mostly from suburban farming, seemed also to 
have adopted to Urban conditions by breeding in tannery water and 
complete shaded ditches.  An. Arabiensis (An. Gambia species b) is the 
only member of Gambia complex present in the Sudan, Omer and 
Cloudsley Thomoson (1968). 
 Khartoum city compared to Khartoum North and Omdrman had 
the richest breeding sites both in numbers and varieties because of greater 
urban practices utilizing water and the siphon drainage network which is 
badly managed.  The cultivated landscape around the city which more or 
less provides fresh water for mosquito breeding is also very extensive.  
Under such a conducive situation there is a direct threat to public health 
from outbreak of unknown arboviral diseases.  Beside Cx. 
Quinquefasciatus the well known vector of filariasis, Cx. Univittatus 
Cx.antennatus and Cx theieri were incriminated in arboviruses 
transmission Ralph (1985). 
 
 Wacheraia bancrofti was found to adapt readily to Cx. 
Quinquefasciatus Wharton (1960). Tests in Kenya and Tanzania revealed 
that Cx. Quinquefasciatus acquirement to Wacheraria infections were 60-
90%.  Magayuka and white (1972). In crowded cities of eastern Africa 
coast Cx. Quinquefasciatus was evidently an important vector.  
 The ability of Cx. Quinquefasciatus to transmit arboviruses like 
chikungynya virus was reported from southern Tanzania Van Someren 
(1966) Woodall (1965). 
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 The wide distribution of Cx. Quinquefasciatus coupled with influx 
of people from bancroftian filariasis indemic areas towards Khartoum, 
May favour the flare up of this disease. 
         All these mentioned data show a wide distribution of mosquitoe 
population in Khartoum state which constitutes a major public health 
hazard to the community.     
 
 
 
 
 
 
 
 
 
 
Conclusions: 
In conclusions from all the data collected by previous authors, it 
seems that RVF in Sudan is prevalent in subclinical form, but the lack 
and poor of reporting system of the clinical cases did not reflect the real 
situation. In the year 2002 outbreaks of RVF were diagnosed in 
Khartoum and River Nile States by IgM ELISA and RT-PCR. The 
combined results of RT-PCR and IgM detection were in 100 % 
concordance with the results of virus isolation. 
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  This limited investigation about mosquitoes showed that Khartoum 
State the capital city of Sudan and their suburban localities host high 
density of mosquitoes which established as a result of urban and 
agricultural increased utility of water coupled with poor sanitary 
awareness.                
Recommendations: 
         Continuous monitoring of RVFV, in sentinel herds and in blood from 
human volunteers, through routine surveillance for virus and associated 
vector transmission would be the backbone of the epidemiologic studies 
on RVF in Sudan. In the absence of clinical hemorrhagic disease, sentinel 
cattle herds may provide an effective approach for monitoring animal 
health and incursion of RVFV isolates. 
         Further investigations are required to know the reservoir of RVFV, 
the situation in human and an entomological study is a must. 
        The application of Remote Senescing Satellite (RSS),Geographical 
Information System (GIS) and bioengineering to study the molecular 
epidemiology of the emerging viral infection should facilitate detection of 
an active RVFV infections, thus enhances humans and animal health 
monitoring. Vaccination and control programs for RVF could be facilitated 
by development and administration of a killed vaccine. Because of the 
segmented nature of the virus and the presence of different strains of 
RVFV, prevention of the disease by vaccination with attenuated live virus 
vaccines is a valid option.  The attenuated vaccines should only be 
administered during the period of the year when the vectors are inactive.  In 
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addition, the use of a recombinant vaccine may limit the level of 
transmission of RVFV and the extent of RVF in the near future. 
         Extensive sprays must be applied in the houses, farms every possible 
mosquito breeding sites, also the use of insects repellent and impregnated 
nets to minimize or completely destroy the mosquito population to  break 
the life cycle of the virus,  
       Community awareness about the disease and the vector is the 
responsibility of all.   
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                                                  Appendices 
                                          Appendix 1 
1.  Deionized distilled Water (DDW): 
      Water was distilled to get rid of salts and passed through deionizer to 
get rid of ions. DDW was used in the preparation of solutions and 
washing of equipments. 
                                       Appendix 2 
2. Phosphate Buffer Saline (PBS) 
Solution A  
NaCl……………………………………………………………16 gm                                
KCl……………………………………………………………0.4 gm                                 
Na2HPO4 (anhydrous)………………………....………………2.3 gm                               
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KHPO4………………………………………………………...0.4 gm                                
DDWcompletedto……………………………………………1500ml    
Solution B 
MgCl2(hydrous)………………………...................................0.426 gm                              
DDW completed to……………………………………………..200 ml  
Solution C 
CaCl2………………………………………………………....0.264 gm                              
DDW completed to…………………..........................................200 ml  
The three solutions A, B and C were autoclaved separately at 121 for 30 
minutes and left to cool. The solution A was added to solution B, and 
then followed by solution C, then the mixture was completed to 2000 ml 
with sterile DDW. The pH was adjusted by adding a few drops of neutral 
red. 
                                       Appendix 3 
3. Phosphate Diluent: 
NaCl …………………………………………………………16.0gm  
KCl…………………………………………………………….0.4gm 
Na2HPO4 (anhydrous)………………………………………… 2.3gm                               
KHPO4........................................................................................0.4gm.                               
DDW completed to…………………………………………..2000ml  
The solution was sterilized by autoclaving at 1215C for 30 minutes. 
 
                                   Appendix 4 
4. Trypsin (7.5%) 
Trypsin powder…………..............................................................37.5gm                           
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 PD completed to………………………………………………5oo ml                                
The solutions were sterilized by filtration. 
 
                                        Appendix 5 
 5. Tris buffer (tri-hydroxymethyl amino-methane) 
Tris…………………………………………………………… 2.42gm                                  
           0.2M HCl………………………………..….76.7ml  Adjust to   pH7.4 
DDW completed to……...….………………………………….400 ml 
This is a 0.05M solution. The solution was sterilized by autoclaving at 
1155C for 20 minutes. Stored at 45C till use. 
 
                                                Appendix 6 
6. Mounting glycerol buffer:  
              Fluorescent antibody rinsing buffer(FA) 
Na2Co3………………………………………………………11.4gm 
NaCl………………………………………………………..... 8.5gm 
DDW completed to...………………………………………..1000ml 
         Adjust pH 9.0-9.5, this is a 4X solution and should be diluted with 
DDW to 1X. Keep in a tightly stopper container at room temperature. 
 Mounting glycerol buffer is prepared by mixing glycerol and FA         
buffer in equal amount.  
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                                       Appendix 7 
6. Tris-boric acid- EDTA (TBE)  
Tri-hydroxymethylamino-methane 0.8M…………………..…107.81g                               
Boric acid 0.89 M……………………………………….........55.03gm  
Ethylene-diamine-tetra-acetic acid (EDTA) 0.2 M 2H20……...7.44gm                               
DDW completed to………………………………………........1000 ml                              
The mixture (10XTBE was dissolved on magnetic stirrer, kept at room 
temperature and then used as 1x concentration for gel preparation and 
electrophoresis.). 
 
 
                                         Appendix 8 
7.  1% agarose gel  
One gm of agarose powder (Molecular biology grade) was suspended in 
100 ml of tris-boric acid EDTA (TBE) buffer. The suspension was heated 
in microwave oven for 3 minutes until the solution was clear. When 
cooled, 40 ml of the melted agarose was poured in the gel try loaded with 
a comb.   
